1
|
Pandey P, Elsori D, Kumar R, Lakhanpal S, Rautela I, Alqahtani TM, Ahmad F, Iqbal D, Khan F. Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents. Front Pharmacol 2024; 15:1399677. [PMID: 38738178 PMCID: PMC11082342 DOI: 10.3389/fphar.2024.1399677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2024] [Accepted: 04/04/2024] [Indexed: 05/14/2024] Open
Abstract
Liver cancer is the second leading cause of cancer-related death worldwide. However, treatment options, including surgical resection, transplantation, and molecular drug therapies, are of limited effectiveness. Recent studies have demonstrated that suppressing ferroptosis might be a pivotal signal for liver cancer initiation, thus providing a new way to combat liver cancer. Ferroptosis is a distinct form of controlled cell death that differs from conventional cell death routes like apoptosis, necrosis, and pyroptosis. It results from intracellular iron overload, which raises iron-dependent reactive oxygen species. This, in turn, leads to the accumulation of lipid peroxides that further result in oxidative damage to cell membranes, disrupt normal functioning, and ultimately speed up the ferroptosis phenomenon. Ferroptosis regulation is intricately linked to cellular physiological processes, encompassing iron metabolism, lipid metabolism, and the equilibrium between oxygen-free radical reactions and lipid peroxidation. This review intends to summarize the natural compounds targeting ferroptosis in liver cancer to offer new therapeutic ideas for liver cancer. Furthermore, it serves as the foundation for identifying and applying chemical medicines and natural chemicals that target ferroptosis to treat liver cancer efficiently.
Collapse
Affiliation(s)
- Pratibha Pandey
- Centre of Research Impact and Outcome, Chitkara University, Rajpura, Punjab, India
| | - Deena Elsori
- Faculty of Resilience, Rabdan Academy, Abu Dhabi, United Arab Emirates
| | - Rahul Kumar
- Chitkara Centre for Research and Development, Chitkara University, Baddi, Himachal Pradesh, India
| | - Sorabh Lakhanpal
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India
| | - Indra Rautela
- School of Applied and Life Sciences, Uttaranchal University, Dehradun, India
| | - Tariq Mohammed Alqahtani
- Department of Radiology and Medical Imaging, College of Applied Medical Sciences, Majmaah university, Al Majma’ah, Saudi Arabia
| | - Fuzail Ahmad
- Respiratory Care Department, College of Applied Sciences, Almaarefa University, Riyadh, Saudi Arabia
| | - Danish Iqbal
- Department of Health Information Management, College of Applied Medical Sciences, Buraydah Private Colleges, Buraydah, Saudi Arabia
| | - Fahad Khan
- Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
| |
Collapse
|
2
|
Khan F, Pandey P, Verma M, Ramniwas S, Lee D, Moon S, Park MN, Upadhyay TK, Kim B. Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy. Biomed Pharmacother 2024; 173:116363. [PMID: 38479184 DOI: 10.1016/j.biopha.2024.116363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Revised: 02/24/2024] [Accepted: 02/27/2024] [Indexed: 03/27/2024] Open
Abstract
Ferroptosis, a novel form of regulated cell death characterized by dependence on iron and lipid peroxidation, has been implicated in a wide range of clinical conditions including neurological diseases, cardiovascular disorders, acute kidney failure, and various types of cancer. Therefore, it is critical to suppress cancer progression and proliferation. Ferroptosis can be triggered in cancer cells and some normal cells by synthetic substances, such as erastin, Ras-selective lethal small molecule-3, or clinical pharmaceuticals. Natural bioactive compounds are traditional drug discovery tools, and some have been therapeutically used as dietary additives or pharmaceutical agents against various malignancies. The fact that natural products have multiple targets and minimal side effects has led to notable advances in anticancer research. Research has indicated that ferroptosis can also be induced by natural compounds during cancer treatment. In this review, we focused on the most recent developments in emerging molecular processes and the significance of ferroptosis in cancer. To provide new perspectives on the future development of ferroptosis-related anticancer medications, we also provide a summary of the implications of natural phytochemicals in triggering ferroptosis through ROS production and ferritinophagy induction in a variety of malignancies.
Collapse
Affiliation(s)
- Fahad Khan
- Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India
| | - Pratibha Pandey
- Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
| | - Meenakshi Verma
- University Centre for Research and Development, Chandigarh University, Gharuan, Mohali, Punjab 140413, India; Department of Chemistry, University Institute of Sciences, Chandigarh University, Gharuan, Mohali, Punjab 140413, India
| | - Seema Ramniwas
- University Centre for Research and Development, Chandigarh University, Gharuan, Mohali, Punjab 140413, India
| | - Dain Lee
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea
| | - Seungjoon Moon
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Chansol Hospital of Korean Medicine, 290, Buheung-ro, Bupyeong-gu, Incheon 21390, the Republic of Korea
| | - Moon Nyeo Park
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Research and Development Cell, Parul University, Vadodara 391760, India
| | - Bonglee Kim
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea.
| |
Collapse
|
3
|
Chauhan P, Pandey P, Ramniwas S, Khan F. Review Deciphering the Potential of Nanotherapeutics in Lung Cancer Management. Curr Cancer Drug Targets 2024; 22:CCDT-EPUB-139457. [PMID: 38561624 DOI: 10.2174/0115680096302203240308104740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2024] [Revised: 02/12/2024] [Accepted: 02/21/2024] [Indexed: 04/04/2024]
Abstract
Lung cancer remains a formidable challenge in oncology, necessitating the develop-ment of more effective prognostic and diagnostic techniques due to inefficient conventional therapeutic approaches and inadequate methods for early lung cancer diagnosis. Despite im-mense progress in the development of innovative strategies to alleviate the impact of this devas-tating disease, the outcomes, unfortunately, remain unsatisfactory, particularly in targeted drug delivery methods. Consequently, nanotechnology has emerged as a revolutionary force in cancer research to develop more effective targeted drug delivery tools due to its extraordinary capacity at the atomic and molecular levels. It has appeared as a beacon of hope in this area of unmet need, providing innovative ways for the prognosis and diagnosis of lung carcinoma. Therefore, this comprehensive review delves into the evolving field of nano-based therapeutics, shedding light on their potential to transform lung cancer treatment. This study meticulously explores the most promising nano-based strategies that have been extensively linked with the treatment of lung carcinoma and mainly emphasizes targeted drug delivery methods and therapies. Addition-ally, this review encapsulates the favorable results of clinical trials, which support the potential pathways for further development of nanotherapeutics in lung cancer management.
Collapse
Affiliation(s)
- Prashant Chauhan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, Uttar Pradesh, India
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, Uttar Pradesh, India
| | - Seema Ramniwas
- University Centre of Research and Development, University institute of Biotechnology, Chandigarh University Gharuan, Mohali, Punjab, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, Uttar Pradesh, India
| |
Collapse
|
4
|
Pandey P, Khan F, Ramniwas S, Saeed M, Ahmad I. A mechanistic review of the pharmacological potential of narirutin: a dietary flavonoid. Naunyn Schmiedebergs Arch Pharmacol 2024:10.1007/s00210-024-03022-w. [PMID: 38457040 DOI: 10.1007/s00210-024-03022-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/06/2024] [Accepted: 02/22/2024] [Indexed: 03/09/2024]
Abstract
Flavanones, a type of polyphenol, are found in substantial amounts in citrus fruits. When high- or moderate-dose orange juice consumption occurs, flavanones make up a significant portion of the total polyphenols in plasma. Disaccharide derivative narirutin, mainly dihydroxy flavanone, is found in citrus fruits. The substantial chemotherapeutic potential of narirutin has been amply demonstrated by numerous experimental studies. Consequently, the purpose of this study is to compile the research that has already been done showing narirutin to be a promising anticancer drug, with its mechanism of action being documented in treatment plans for various cancer forms. Narirutin functions in a variety of cancer cells by regulating several pathways that include cell cycle arrest, apoptosis, antiangiogenic, antimetastatic, and DNA repair. Narirutin has been shown to modify many molecular targets linked to the development of cancer, including drug transporters, cell cycle mediators, transcription factors, reactive oxygen species, reactive nitrogen species, and inflammatory cytokines. Taken together, these reviews offer important new information about narirutin's potential as a potent and promising drug candidate for use in medicines, functional foods, dietary supplements, nutraceuticals, and other products targeted at improving the treatment of cancer.
Collapse
Affiliation(s)
- Pratibha Pandey
- University Centre for Research and Development, University Institute of Biotechnology, Chandigarh University, Gharuan, Mohali, Punjab, India
| | - Fahad Khan
- Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India.
| | - Seema Ramniwas
- University Centre for Research and Development, University Institute of Biotechnology, Chandigarh University, Gharuan, Mohali, Punjab, India
| | - Mohd Saeed
- Department of Biology, College of Science, University of Hail, Hail, Saudi Arabia
| | - Irfan Ahmad
- Department of Clinical Laboratory Sciences, College of Applied Medical Science, King Khalid University, Abha, Saudi Arabia
| |
Collapse
|
5
|
Tyagi S, Mishra R, Mazumder A, Mazumder R, Singh G, Pandey P. Synthesis, in silico screening, and biological evaluation of novel pyridine congeners as anti-epileptic agents targeting AMPA (α-amino-3-hydroxy-5-methylisoxazole) receptors. Chem Biol Drug Des 2024; 103:e14498. [PMID: 38453241 DOI: 10.1111/cbdd.14498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2023] [Revised: 12/23/2023] [Accepted: 02/26/2024] [Indexed: 03/09/2024]
Abstract
The research involves the synthesis of a series of new pyridine analogs 5(i-x) and their evaluation for anti-epileptic potential using in silico and in vivo models. Synthesis of the compounds was accomplished by using the Vilsmeier-Haack reaction principle. AutoDock 4.2 was used for their in silico screening against AMPA (-amino-3-hydroxy-5-methylisoxazole) receptor (PDB ID:3m3f). For in vivo testing, the maximal electroshock seizure (MES) model was used. The physicochemical, pharmacokinetic, drug-like, and drug-score features of all synthesized compounds were assessed using the online Swiss ADME and Protein Plus software. The in silico results showed that all the synthesized compounds 5(i-x) had 1-3 interactions and affinities ranging from -6.5 to -8.0 kJ/mol with the targeted receptor compared to the binding affinities of the standard drug phenytoin and the original ligand of the target (P99), which were -7.6 and -6.8 kJ/mol, respectively. In vivo study results showed that the compound 5-Carbamoyl-2-formyl-1-[2-(4-nitrophenyl)-2-oxo-ethyl]-pyridinium gave 60% protection against epileptic seizures compared to 59% protection afforded by regular phenytoin. All of them met Lipinski's rule of five and had drug-likeness and drug score values of 0.55 and 0.8, respectively, making them chemically and functionally like phenytoin. According to the findings of the studies, the synthesized derivatives have the potential to be employed as a stepping stone in the development of novel anti-epileptic drugs.
Collapse
Affiliation(s)
- Shivani Tyagi
- Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, Uttar Pradesh, India
| | - Rakhi Mishra
- Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, Uttar Pradesh, India
| | - Avijit Mazumder
- Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, Uttar Pradesh, India
| | - Rupa Mazumder
- Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, Uttar Pradesh, India
| | - Gurvinder Singh
- School of Pharmaceutical Science, Lovely Professional University, Phagwara, Punjab, India
| | - Pratibha Pandey
- Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, Uttar Pradesh, India
- Noida Institute of Engineering and Technology, Biotechnology Department, Greater Noida, Uttar Pradesh, India
| |
Collapse
|
6
|
Khan F, Pandey P, Verma M, Upadhyay TK. Terpenoid-Mediated Targeting of STAT3 Signaling in Cancer: An Overview of Preclinical Studies. Biomolecules 2024; 14:200. [PMID: 38397437 PMCID: PMC10886526 DOI: 10.3390/biom14020200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2024] [Revised: 02/01/2024] [Accepted: 02/05/2024] [Indexed: 02/25/2024] Open
Abstract
Cancer has become one of the most multifaceted and widespread illnesses affecting human health, causing substantial mortality at an alarming rate. After cardiovascular problems, the condition has a high occurrence rate and ranks second in terms of mortality. The development of new drugs has been facilitated by increased research and a deeper understanding of the mechanisms behind the emergence and advancement of the disease. Numerous preclinical and clinical studies have repeatedly demonstrated the protective effects of natural terpenoids against a range of malignancies. Numerous potential bioactive terpenoids have been investigated in natural sources for their chemopreventive and chemoprotective properties. In practically all body cells, the signaling molecule referred to as signal transducer and activator of transcription 3 (STAT3) is widely expressed. Numerous studies have demonstrated that STAT3 regulates its downstream target genes, including Bcl-2, Bcl-xL, cyclin D1, c-Myc, and survivin, to promote the growth of cells, differentiation, cell cycle progression, angiogenesis, and immune suppression in addition to chemotherapy resistance. Researchers viewed STAT3 as a primary target for cancer therapy because of its crucial involvement in cancer formation. This therapy primarily focuses on directly and indirectly preventing the expression of STAT3 in tumor cells. By explicitly targeting STAT3 in both in vitro and in vivo settings, it has been possible to explain the protective effect of terpenoids against malignant cells. In this study, we provide a complete overview of STAT3 signal transduction processes, the involvement of STAT3 in carcinogenesis, and mechanisms related to STAT3 persistent activation. The article also thoroughly summarizes the inhibition of STAT3 signaling by certain terpenoid phytochemicals, which have demonstrated strong efficacy in several preclinical cancer models.
Collapse
Affiliation(s)
- Fahad Khan
- Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 602105, India;
| | - Pratibha Pandey
- University Centre for Research and Development, Chandigarh University, Gharuan, Mohali 140413, India
| | - Meenakshi Verma
- University Centre for Research and Development, Chandigarh University, Gharuan, Mohali 140413, India
- Department of Chemistry, University Institute of Sciences, Chandigarh University, Gharuan, Mohali 140413, India
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Research and Development Cell, Parul University, Vadodara 391760, India;
| |
Collapse
|
7
|
Kumar A, Mazumder R, Rani A, Pandey P, Khurana N. Novel Approaches for the Management of Type 2 Diabetes Mellitus: An Update. Curr Diabetes Rev 2024; 20:e051023221768. [PMID: 37888820 DOI: 10.2174/0115733998261903230921102620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 08/06/2023] [Accepted: 08/10/2023] [Indexed: 10/28/2023]
Abstract
Diabetes mellitus is an irreversible, chronic metabolic disorder indicated by hyperglycemia. It is now considered a worldwide pandemic. T2DM, a spectrum of diseases initially caused by tissue insulin resistance and slowly developing to a state characterized by absolute loss of secretory action of the β cells of the pancreas, is thought to be caused by reduced insulin secretion, resistance to tissue activities of insulin, or a combination of both. Insulin secretagogues, biguanides, insulin sensitizers, alpha-glucosidase inhibitors, incretin mimetics, amylin antagonists, and sodium-glucose co-transporter-2 (SGLT2) inhibitors are the main medications used to treat T2DM. Several of these medication's traditional dosage forms have some disadvantages, including frequent dosing, a brief half-life, and limited absorption. Hence, attempts have been made to develop new drug delivery systems for oral antidiabetics to ameliorate the difficulties associated with conventional dosage forms. In comparison to traditional treatments, this review examines the utilization of various innovative therapies (such as microparticles, nanoparticles, liposomes, niosomes, phytosomes, and transdermal drug delivery systems) to improve the distribution of various oral hypoglycemic medications. In this review, we have also discussed some new promising candidates that have been approved recently by the US Food and Drug Administration for the treatment of T2DM, like semaglutide, tirzepatide, and ertugliflozin. They are used as a single therapy and also as combination therapy with drugs like metformin and sitagliptin.
Collapse
Affiliation(s)
- Abhishek Kumar
- Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, UP 201306, India
| | - Rupa Mazumder
- Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, UP 201306, India
| | - Anjna Rani
- Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, UP 201306, India
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP 201306, India
| | - Navneet Khurana
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India
| |
Collapse
|
8
|
Pandey P, Khan F, Singh M, Verma A, Kumar H, Mazumder A, Rakhra G. Study Deciphering the Crucial Involvement of Notch Signaling Pathway in Human Cancers. Endocr Metab Immune Disord Drug Targets 2023:EMIDDT-EPUB-136234. [PMID: 37997805 DOI: 10.2174/0118715303261691231107113548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Revised: 09/26/2023] [Accepted: 09/28/2023] [Indexed: 11/25/2023]
Abstract
In recent years, dysregulation of the notch pathway has been associated with the development and progression of various cancers. Notch signaling is involved in several cellular processes such as proliferation, differentiation, apoptosis, and angiogenesis, and its abnormal activation can lead to uncontrolled cell growth and tumorigenesis. In various cancers, the Notch pathway has been shown to have both tumor-promoting and tumor-suppressive effects, depending on the context and stage of cancer development. In some cases, activation of the Notch pathway has been shown to promote tumor growth and progression, while in others it has been shown to inhibit tumor growth and induce cell death. The Notch pathway has been found to be particularly important in the development of leukaemia, breast cancer, lung cancer and pancreatic cancer. In leukaemia, the Notch pathway is often activated, which promotes the survival and proliferation of leukaemia cells. In breast cancer, Notch signaling has been implicated in tumor initiation and maintenance of cancer stem cells. In cervical cancer, the Notch signaling pathway has been shown to play a crucial role in the development of the disease. In lung cancer, Notch activation promotes cancer cell proliferation and migration, while in pancreatic cancer, Notch signaling is associated with tumor initiation and resistance to chemotherapy. Understanding the role of the Notch pathway in cancer development and progression may provide new opportunities for the development of targeted therapies for cancer treatment. Several drugs targeting the Notch pathway are currently in preclinical or clinical development and may hold promise for anticancer therapy in the future.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India
| | - Megha Singh
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India
| | - Aditi Verma
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India
| | - Hariom Kumar
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India
| | - Avijit Mazumder
- Department of Pharmacology, Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, 201306, India
| | - Gurmeen Rakhra
- Department of Biochemistry, Lovely Professional University, Phagwara, Punjab, India
| |
Collapse
|
9
|
Pandey P, Khan F, Upadhyay TK, Seungjoon M, Park MN, Kim B. Corrigendum to "New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies" [Biomed. Pharmacother. 161 (2023) 114491]. Biomed Pharmacother 2023; 167:115388. [PMID: 37741799 DOI: 10.1016/j.biopha.2023.115388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/25/2023] Open
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India.
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India
| | - Moon Seungjoon
- Chansol Hospital of Korean Medicine, 290, Buheung-ro, Bupyeong-gu, Incheon 21390, the Republic of Korea; Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea
| | - Moon Nyeo Park
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea
| | - Bonglee Kim
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea.
| |
Collapse
|
10
|
Arif M, Pandey P, Khan F. Review Deciphering the Anticancer Efficacy of Resveratrol and their Associated Mechanisms in Human Carcinoma. Endocr Metab Immune Disord Drug Targets 2023; 24:EMIDDT-EPUB-135721. [PMID: 37929735 DOI: 10.2174/0118715303251351231018145903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Revised: 09/14/2023] [Accepted: 09/20/2023] [Indexed: 11/07/2023]
Abstract
The scientific world has recently shown wider attention to elucidating the anticancerous potential of numerous plant-based bioactive compounds. Many research studies have suggested that consuming foods high in polyphenols, which are present in large amounts in grains, legumes, vegetables, and fruits, may delay the onset of various illnesses, including cancer. Normal cells with genetic abnormalities begin the meticulously organized path leading to cancer, which causes the cells to constantly multiply, colonize, and metastasize to other organs like the liver, lungs, colon, and brain. Resveratrol is a naturally occurring stilbene and non-flavonoid polyphenol, a phytoestrogen with antioxidant, anti-inflammatory, cardioprotective, and anticancer properties. Resveratrol makes cancer cells more susceptible to common chemotherapeutic treatments by reversing multidrug resistance in cancer cells. This is especially true when combined with clinically used medications. Several new resveratrol analogs with enhanced anticancer effectiveness, absorption, and pharmacokinetic profile have been discovered. The present emphasis of this review is the modulation of intracellular molecular targets by resveratrol in vivo and in vitro in various malignancies. This review would help future researchers develop a potent lead candidate for efficiently managing human cancers.
Collapse
Affiliation(s)
- Mohd Arif
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, U.P., India
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, U.P., India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, U.P., India
| |
Collapse
|
11
|
Chauhan P, Pandey P, Khan F, Maqsood R. Insights on the Correlation between Mitochondrial Dysfunction and the Progression of Parkinson's Disease. Endocr Metab Immune Disord Drug Targets 2023; 23:EMIDDT-EPUB-135408. [PMID: 37867265 DOI: 10.2174/0118715303249690231006114308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/17/2023] [Revised: 08/09/2023] [Accepted: 08/30/2023] [Indexed: 10/24/2023]
Abstract
The aetiology of a progressive neuronal Parkinson's disease has been discussed in several studies. However, due to the multiple risk factors involved in its development, such as environmental toxicity, parental inheritance, misfolding of protein, ageing, generation of reactive oxygen species, degradation of dopaminergic neurons, formation of neurotoxins, mitochondria dysfunction, and genetic mutations, its mechanism of involvement is still discernible. Therefore, this study aimed to review the processes or systems that are crucially implicated in the conversion of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) into its lethal form, which directly blockades the performance of mitochondria, leading to the formation of oxidative stress in the dopaminergic neurons of substantia nigra pars compacta (SNpc) and resulting in the progression of an incurable Parkinson's disease. This review also comprises an overview of the mutated genes that are frequently associated with mitochondrial dysfunction and the progression of Parkinson's disease. Altogether, this review would help future researchers to develop an efficient therapeutic approach for the management of Parkinson's disease via identifying potent prognostic and diagnostic biomarkers.
Collapse
Affiliation(s)
- Prashant Chauhan
- Department of Biotechnology, Noida Institute of Engineering and Technology, India
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, India
| | - Ramish Maqsood
- Department of Biotechnology, Noida Institute of Engineering and Technology, India
| |
Collapse
|
12
|
Pandey P, Khan F. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities. Biochim Biophys Acta Gen Subj 2023; 1867:130401. [PMID: 37307905 DOI: 10.1016/j.bbagen.2023.130401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Revised: 05/23/2023] [Accepted: 06/06/2023] [Indexed: 06/14/2023]
Abstract
Gut microbiota is regarded as a crucial regulator of the immune system. Healthy gut microbiota plays a specialized role in host xenobiotics, nutrition, drug metabolism, regulation of the structural integrity of the gut mucosal barrier, defense against infections, and immunomodulation. It is now understood that any imbalance in gut microbiota composition from that present in a healthy state is linked to genetic susceptibility to a number of metabolic disorders, including diabetes, autoimmunity, and cancer. Recent research has suggested that immunotherapy can treat many different cancer types with fewer side effects and better ability to eradicate tumors than conventional chemotherapy or radiotherapy. However, a significant number of patients eventually develop immunotherapy resistance. A strong correlation was observed between the composition of the gut microbiome and the effectiveness of treatment by examining the variations between populations that responded to immunotherapy and those that did not. Therefore, we suggest that modulating the microbiome could be a potential adjuvant therapy for cancer immunotherapy and that the architecture of the gut microbiota may be helpful in explaining the variation in treatment response. Herein, we focus on recent research on the interactions among the gut microbiome, host immunity, and cancer immunotherapy. In addition, we highlighted the clinical manifestations, future opportunities, and limitations of microbiome manipulation in cancer immunotherapy.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida 201306, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida 201306, India.
| |
Collapse
|
13
|
Diehl S, Trotta N, Joo K, Achenbach P, Akbar Z, Armstrong WR, Atac H, Avakian H, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biselli AS, Bossù F, Brinkmann KT, Briscoe WJ, Bulumulla D, Burkert V, Capobianco R, Carman DS, Carvajal JC, Celentano A, Charles G, Chatagnon P, Chesnokov V, Ciullo G, Cole PL, Contalbrigo M, Costantini G, Crede V, D'Angelo A, Dashyan N, De Vita R, Deur A, Djalali C, Dupre R, Ehrhart M, El Alaoui A, El Fassi L, Elouadrhiri L, Fegan S, Filippi A, Gavalian G, Glazier DI, Golubenko AA, Gosta G, Gothe RW, Gotra Y, Griffioen K, Hafidi K, Hakobyan H, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Illari I, Ireland DG, Isupov EL, Jo HS, Johnston R, Keller D, Khachatryan M, Khanal A, Kim A, Kim W, Klimenko V, Kripko A, Kubarovsky V, Kuhn SE, Lagerquist V, Lanza L, Leali M, Lee S, Lenisa P, Li X, MacGregor IJD, Marchand D, Mascagna V, Matousek G, McKinnon B, McLauchlin C, Meziani ZE, Migliorati S, Milner RG, Mineeva T, Mirazita M, Mokeev V, Moran P, Munoz Camacho C, Naidoo P, Neupane K, Niccolai S, Niculescu G, Osipenko M, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Paul SJ, Phelps W, Pilleux N, Pokhrel M, Poudel J, Price JW, Prok Y, Radic A, Raue BA, Reed T, Richards J, Ripani M, Ritman J, Rossi P, Sabatié F, Salgado C, Schadmand S, Schmidt A, Sharabian YG, Shrestha U, Sokhan D, Sparveris N, Spreafico M, Stepanyan S, Strakovsky I, Strauch S, Turisini M, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Voutier E, Watts DP, Wei X, Williams R, Wishart R, Wood MH, Yurov M, Zachariou N, Zhao ZW, Zurek M. First Measurement of Hard Exclusive π^{-}Δ^{++} Electroproduction Beam-Spin Asymmetries off the Proton. Phys Rev Lett 2023; 131:021901. [PMID: 37505937 DOI: 10.1103/physrevlett.131.021901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 05/22/2023] [Accepted: 06/20/2023] [Indexed: 07/30/2023]
Abstract
The polarized cross-section ratio σ_{LT^{'}}/σ_{0} from hard exclusive π^{-}Δ^{++} electroproduction off an unpolarized hydrogen target has been extracted based on beam-spin asymmetry measurements using a 10.2 GeV/10.6 GeV incident electron beam and the CLAS12 spectrometer at Jefferson Lab. The study, which provides the first observation of this channel in the deep-inelastic regime, focuses on very forward-pion kinematics in the valence regime, and photon virtualities ranging from 1.5 GeV^{2} up to 7 GeV^{2}. The reaction provides a novel access to the d-quark content of the nucleon and to p→Δ^{++} transition generalized parton distributions. A comparison to existing results for hard exclusive π^{+}n and π^{0}p electroproduction is provided, which shows a clear impact of the excitation mechanism, encoded in transition generalized parton distributions, on the asymmetry.
Collapse
Affiliation(s)
- S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - N Trotta
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P Achenbach
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Z Akbar
- Florida State University, Tallahassee, Florida 32306, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | | | - I Bedlinskiy
- National Research Centre Kurchatov Institute-TEP, Moscow, 117259, Russia
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - A S Biselli
- Fairfield University, Fairfield Connecticut 06824, USA
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - K-T Brinkmann
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Capobianco
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - G Charles
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Chesnokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Ciullo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - P L Cole
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - V Crede
- Florida State University, Tallahassee, Florida 32306, USA
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Dupre
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Ehrhart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - G Gavalian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Gosta
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Y Gotra
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Hattawy
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - I Illari
- The George Washington University, Washington, D.C. 20052, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - R Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M Khachatryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - V Klimenko
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Lagerquist
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - S Lee
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Lenisa
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - X Li
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - G Matousek
- Duke University, Durham, North Carolina 27708-0305, USA
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - C McLauchlin
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Migliorati
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - R G Milner
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Moran
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Naidoo
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L L Pappalardo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - R Paremuzyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S J Paul
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
- The George Washington University, Washington, D.C. 20052, USA
| | - N Pilleux
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Pokhrel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Radic
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - J Richards
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Institute fur Kernphysik (Juelich), Juelich, Germany
| | - P Rossi
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - S Schadmand
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
- Ohio University, Athens, Ohio 45701, USA
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - M Spreafico
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - M Turisini
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Williams
- University of York, York YO10 5DD, United Kingdom
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York 14208-1517, USA
| | - M Yurov
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Zurek
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
14
|
Pandey P, Khan F, Khan MA, Kumar R, Upadhyay TK. An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers. Nutrients 2023; 15:3111. [PMID: 37513529 PMCID: PMC10385528 DOI: 10.3390/nu15143111] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2023] [Revised: 07/05/2023] [Accepted: 07/10/2023] [Indexed: 07/30/2023] Open
Abstract
Apitherapy (using bee products) has gained broad recognition in cancer therapeutics globally. Honeybee venom has a broad range of biological potential, and its utilization is rapidly emerging in apitherapy. Bee products have significant potential to strengthen the immune system and improve human health. Thus, this review is targeted toward recapitulating the chemo-preventive potential of melittin (MEL), which constitutes a substantial portion of honeybee venom. Honeybee venom (apitoxin) is produced in the venom gland of the honeybee abdomen, and adult bees utilize it as a primary colony defense mechanism. Apitoxin comprises numerous biologically active compounds, including peptides, enzymes, amines, amino acids, phospholipids, minerals, carbohydrates, and volatile components. We are mainly focused on exploring the potential of melittin (a peptide component) of bee venom that has shown promising potential in the treatment of several human cancers, including breast, stomach, lung, prostate, ovary, kidney, colon, gastric, esophageal, cervical cancers, melanoma, osteosarcoma, and hepatocellular carcinoma. This review has summarized all potential studies related to the anticancerous efficacy of melittin (apitoxin), its formulations, conjugates, and nano-formulations against several human carcinomas, which would further pave the way for future researchers in developing potent drugs for cancer management.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, Uttar Pradesh, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, Uttar Pradesh, India
| | - Minhaj Ahmad Khan
- Department of Biochemistry, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India
| | - Rajnish Kumar
- Department of Pharmaceutical Chemistry, Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida 201306, Uttar Pradesh, India
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, Gujarat, India
| |
Collapse
|
15
|
Pandey P, Khan F, Upadhyay TK, Giri PP. Therapeutic efficacy of caffeic acid phenethyl ester in cancer therapy: An updated review. Chem Biol Drug Des 2023; 102:201-216. [PMID: 36929632 DOI: 10.1111/cbdd.14233] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2022] [Revised: 01/31/2023] [Accepted: 02/28/2023] [Indexed: 03/18/2023]
Abstract
Nowadays, there is a lot of public and scientific interest in using phytochemicals to treat human ailments. Existing cancer medicines still run across obstacles, despite significant advancements in the field. For instance, chemotherapy may result in severe adverse effects, increased drug resistance, and treatment failure. Natural substances that are phytochemically derived provide innovative approaches as potent therapeutic molecules for the treatment of cancer. Bioactive natural compounds may enhance chemotherapy for cancer by increasing the sensitivity of cancer cells to medicines. Propolis has been found to interfere with the viability of cancer cells, among other phytochemicals. Of all the components that make up propolis, caffeic acid phenethyl ester (CAPE) (a flavonoid) has been the subject of the most research. It demonstrates a broad spectrum of therapeutic uses, including antitumor, antimicrobial, antiviral, anti-inflammatory, immunomodulatory, hepatoprotective, neuroprotective, and cardioprotective effects. Studies conducted in vitro and in vivo have demonstrated that CAPE specifically targets genes involved in cell death, cell cycle regulation, angiogenesis, and metastasis. By altering specific signaling cascades, such as the NF-κB signaling pathway, CAPE can limit the proliferation of human cancer cells. This review highlights the research findings demonstrating the anticancer potential of CAPE with a focus on multitargeted molecular and biological implications in various cancer models.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida, India
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara, India
| | - Pavan Prakash Giri
- Department of Chemistry, Noida Institute of Engineering & Technology, Greater Noida, India
| |
Collapse
|
16
|
Pandey P, Khan F, Choi M, Singh SK, Kang HN, Park MN, Ko SG, Sahu SK, Mazumder R, Kim B. Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer. Biomed Pharmacother 2023; 164:114938. [PMID: 37267635 DOI: 10.1016/j.biopha.2023.114938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2023] [Accepted: 05/25/2023] [Indexed: 06/04/2023] Open
Abstract
In the current period of drug development, natural products have provided an unrivaled supply of anticancer medications. By modifying the cancer microenvironment and various signaling pathways, natural products and their derivatives and analogs play a significant role in cancer treatment. These substances are effective against several signaling pathways, particularly the cell death pathways (apoptosis and autophagy) and embryonic developmental pathways (Notch, Wnt, and Hedgehog pathways). Natural products have a long history, but more research is needed to understand their current function in the research and development of cancer treatments and the potential for natural products to serve as a significant source of therapeutic agents in the future. Several target-specific anticancer medications failed to treat cancer, necessitating research into natural compounds with multiple target properties. To help develop a better treatment plan for managing breast cancer, this review has outlined the anticancerous potential of several therapeutic approaches targeting the notch signaling system in breast tumors.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India.
| | - Min Choi
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea
| | - Sujeet Kumar Singh
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India
| | - Han Na Kang
- KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, the Republic of Korea
| | - Moon Nyeo Park
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea
| | - Seong-Gyu Ko
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea
| | - Sanjeev Kumar Sahu
- School of pharmaceutical sciences, Lovely Professional University, Phagwara, Punjab, India
| | - Rupa Mazumder
- Noida Institute of Engineering & Technology (Pharmacy Institute), Greater Noida 201306, India
| | - Bonglee Kim
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea.
| |
Collapse
|
17
|
Christiaens G, Defurne M, Sokhan D, Achenbach P, Akbar Z, Amaryan MJ, Atac H, Avakian H, Gayoso CA, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benkel B, Benmokhtar F, Bianconi A, Biselli AS, Bondi M, Booth WA, Bossù F, Boiarinov S, Brinkmann KT, Briscoe WJ, Bueltmann S, Bulumulla D, Burkert VD, Cao T, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chesnokov V, Chetry T, Ciullo G, Clash G, Cole PL, Contalbrigo M, Costantini G, D'Angelo A, Dashyan N, De Vita R, Deur A, Diehl S, Dilks C, Djalali C, Dupre R, Egiyan H, Ehrhart M, Alaoui AE, Fassi LE, Elouadrhiri L, Fegan S, Filippi A, Gates K, Gavalian G, Ghandilyan Y, Gilfoyle GP, Girod FX, Glazier DI, Golubenko AA, Gosta G, Gothe RW, Gotra Y, Griffioen KA, Guidal M, Hafidi K, Hakobyan H, Hattawy M, Hauenstein F, Hayward TB, Heddle D, Hobart A, Holmberg DE, Holtrop M, Ilieva Y, Ireland DG, Isupov EL, Jo HS, Keller D, Khachatryan M, Khanal A, Kim W, Kripko A, Kubarovsky V, Kuhn SE, Lagerquist V, Lanza L, Kabir ML, Leali M, Lee S, Lenisa P, Li X, Livingston K, MacGregor IJD, Marchand D, Mascagna V, Matousek G, McKinnon B, McLauchlin C, Meziani ZE, Migliorati S, Milner RG, Mineeva T, Mirazita M, Mokeev V, Molina E, Camacho CM, Nadel-Turonski P, Naidoo P, Neupane K, Niccolai S, Nicol M, Niculescu G, Osipenko M, Ouillon M, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Paul SJ, Phelps W, Pilleux N, Pokhrel M, Poudel J, Price JW, Prok Y, Radic A, Ramasubramanian N, Raue BA, Reed T, Richards J, Ripani M, Ritman J, Rossi P, Sabatié F, Salgado C, Schadmand S, Schmidt A, Scott MBC, Sharabian YG, Shirokov EV, Shrestha U, Simmerling P, Sparveris N, Spreafico M, Stepanyan S, Strakovsky II, Strauch S, Tan JA, Trotta N, Turisini M, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Voutier E, Watts DP, Wei X, Williams R, Wishart R, Wood MH, Zachariou N, Zhang J, Zhao ZW, Ziegler V, Zurek M. First CLAS12 Measurement of Deeply Virtual Compton Scattering Beam-Spin Asymmetries in the Extended Valence Region. Phys Rev Lett 2023; 130:211902. [PMID: 37295113 DOI: 10.1103/physrevlett.130.211902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Revised: 03/24/2023] [Accepted: 04/21/2023] [Indexed: 06/12/2023]
Abstract
Deeply virtual Compton scattering (DVCS) allows one to probe generalized parton distributions describing the 3D structure of the nucleon. We report the first measurement of the DVCS beam-spin asymmetry using the CLAS12 spectrometer with a 10.2 and 10.6 GeV electron beam scattering from unpolarized protons. The results greatly extend the Q^{2} and Bjorken-x phase space beyond the existing data in the valence region and provide 1600 new data points measured with unprecedented statistical uncertainty, setting new, tight constraints for future phenomenological studies.
Collapse
Affiliation(s)
- G Christiaens
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - P Achenbach
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Z Akbar
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M J Amaryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Ayerbe Gayoso
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | | | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - B Benkel
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - A S Biselli
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - W A Booth
- University of York, York YO10 5DD, United Kingdom
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K-Th Brinkmann
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - S Bueltmann
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T Cao
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Chesnokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - T Chetry
- Florida International University, Miami, Florida 33199, USA
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
- Ohio University, Athens, Ohio 45701, USA
| | - G Ciullo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Universita' di Ferrara, 44121 Ferrara, Italy
| | - G Clash
- University of York, York YO10 5DD, United Kingdom
| | - P L Cole
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
- Catholic University of America, Washington, D.C. 20064, USA
| | | | - G Costantini
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - C Dilks
- Duke University, Durham, North Carolina 27708-0305, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Dupre
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ehrhart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - K Gates
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - G Gavalian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - F X Girod
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Gosta
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Y Gotra
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - F Hauenstein
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Heddle
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D E Holmberg
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M Khachatryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Lagerquist
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M L Kabir
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - M Leali
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - S Lee
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - P Lenisa
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Universita' di Ferrara, 44121 Ferrara, Italy
| | - X Li
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
| | - G Matousek
- Duke University, Durham, North Carolina 27708-0305, USA
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - C McLauchlin
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Z E Meziani
- Temple University, Philadelphia, Pennsylvania 19122, USA
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Migliorati
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - R G Milner
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Molina
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Naidoo
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Nicol
- University of York, York YO10 5DD, United Kingdom
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Ouillon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- Temple University, Philadelphia, Pennsylvania 19122, USA
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Universita' di Ferrara, 44121 Ferrara, Italy
| | - R Paremuzyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S J Paul
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - W Phelps
- The George Washington University, Washington, D.C. 20052, USA
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - N Pilleux
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Pokhrel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Radic
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | | | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - Trevor Reed
- Florida International University, Miami, Florida 33199, USA
| | - J Richards
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D 64291 Darmstadt, Germany
- Institute fur Kernphysik (Juelich), 52428 Juelich, Germany
| | - P Rossi
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - S Schadmand
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D 64291 Darmstadt, Germany
- Institute fur Kernphysik (Juelich), 52428 Juelich, Germany
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - M B C Scott
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E V Shirokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - U Shrestha
- Ohio University, Athens, Ohio 45701, USA
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P Simmerling
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - M Spreafico
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - J A Tan
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - N Trotta
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Turisini
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Williams
- University of York, York YO10 5DD, United Kingdom
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York 14208, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - J Zhang
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - Z W Zhao
- Old Dominion University, Norfolk, Virginia 23529, USA
- Duke University, Durham, North Carolina 27708-0305, USA
| | - V Ziegler
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Zurek
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
18
|
Pandey P, Khan F, Upadhyay TK, Seungjoon M, Park MN, Kim B. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies. Biomed Pharmacother 2023; 161:114491. [PMID: 37002577 DOI: 10.1016/j.biopha.2023.114491] [Citation(s) in RCA: 14] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2023] [Revised: 02/20/2023] [Accepted: 03/07/2023] [Indexed: 03/14/2023] Open
Abstract
Numerous cancers express platelet-derived growth factors (PDGFs) and PDGF receptors (PDGFRs). By directly stimulating tumour cells in an autocrine manner or by stimulating tumour stromal cells in a paracrine manner, the platelet-derived growth factor (PDGF)/platelet-derived growth factor receptor (PDGFR) pathway is crucial in the growth and spread of several cancers. To combat hypoxia in the tumour microenvironment, it encourages angiogenesis. A growing body of experimental data shows that PDGFs target malignant cells, vascular cells, and stromal cells to modulate tumour growth, metastasis, and the tumour microenvironment. To combat medication resistance and enhance patient outcomes in cancers, targeting the PDGF/PDGFR pathway is a viable therapeutic approach. There have been reports of anomalies in the PDGF pathway, including the gain of function point mutations, activating chromosomal translocations, or overexpression or amplification of PDGF receptors (PDGFRs). As a result, it has been shown that targeting the PDGF/PDGFR signaling pathway is an effective method for treating cancer. As a result, this study will concentrate on the regulation of the PDGF/PDGFR signaling system, in particular the current methods and inhibitors used in cancer treatment, as well as the associated therapeutic advantages and side effects.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India.
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India
| | - Moon Seungjoon
- Chansol Hospital of Korean Medicine, 290, Buheung-ro, Bupyeong-gu, Incheon 21390, Republic of Korea; Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, Republic of Korea
| | - Moon Nyeo Park
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
| | - Bonglee Kim
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
| |
Collapse
|
19
|
Pandey P, Khan F, Seifeldin SA, Alshaghdali K, Siddiqui S, Abdelwadoud ME, Vyas M, Saeed M, Mazumder A, Saeed A. Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics. Nutrients 2023; 15:2088. [PMID: 37432240 DOI: 10.3390/nu15092088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2023] [Revised: 04/17/2023] [Accepted: 04/20/2023] [Indexed: 07/12/2023] Open
Abstract
The Wnt pathway has been recognized for its crucial role in human development and homeostasis, but its dysregulation has also been linked to several disorders, including cancer. Wnt signaling is crucial for the development and metastasis of several kinds of cancer. Moreover, members of the Wnt pathway have been proven to be effective biomarkers and promising cancer therapeutic targets. Abnormal stimulation of the Wnt signaling pathway has been linked to the initiation and advancement of cancer in both clinical research and in vitro investigations. A reduction in cancer incidence rate and an improvement in survival may result from targeting the Wnt/β-catenin pathway. As a result, blocking this pathway has been the focus of cancer research, and several candidates that can be targeted are currently being developed. Flavonoids derived from plants exhibit growth inhibitory, apoptotic, anti-angiogenic, and anti-migratory effects against various malignancies. Moreover, flavonoids influence different signaling pathways, including Wnt, to exert their anticancer effects. In this review, we comprehensively evaluate the influence of flavonoids on cancer development and metastasis by focusing on the Wnt/β-catenin signaling pathway, and we provide evidence of their impact on a number of molecular targets. Overall, this review will enhance our understanding of these natural products as Wnt pathway modulators.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida 201306, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida 201306, India
| | - Sara A Seifeldin
- Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, Hail 55476, Saudi Arabia
- Medical and Diagnostic Research Centre, University of Hail, Ha'il 55473, Saudi Arabia
| | - Khalid Alshaghdali
- Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, Hail 55476, Saudi Arabia
- Medical and Diagnostic Research Centre, University of Hail, Ha'il 55473, Saudi Arabia
| | - Samra Siddiqui
- Medical and Diagnostic Research Centre, University of Hail, Ha'il 55473, Saudi Arabia
- Department of Public Health, College of Health Sciences, University of Ha'il, Hail 55476, Saudi Arabia
| | - Mohamed Elfatih Abdelwadoud
- Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, University of Medical Sciences & Technology, Khartoum 11115, Sudan
| | - Manish Vyas
- School of Pharmaceutical Sciences, Lovely Professional University, Punjab 144411, India
| | - Mohd Saeed
- Department of Biology, College of Sciences, University of Hail, Ha'il 34464, Saudi Arabia
| | - Avijit Mazumder
- Department of Pharmacology, Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida 201306, India
| | - Amir Saeed
- Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, Hail 55476, Saudi Arabia
- Medical and Diagnostic Research Centre, University of Hail, Ha'il 55473, Saudi Arabia
- Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, University of Medical Sciences & Technology, Khartoum 11115, Sudan
| |
Collapse
|
20
|
Chetry T, El Fassi L, Brooks WK, Dupré R, El Alaoui A, Hafidi K, Achenbach P, Adhikari KP, Akbar Z, Armstrong WR, Arratia M, Atac H, Avakian H, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benkel B, Benmokhtar F, Bianconi A, Biselli AS, Bondi M, Booth WA, Bossù F, Boiarinov S, Brinkmann KT, Briscoe WJ, Bulumulla D, Burkert VD, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chesnokov V, Ciullo G, Cole PL, Contalbrigo M, Costantini G, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Djalali C, Egiyan H, Elouadrhiri L, Eugenio P, Fegan S, Filippi A, Gavalian G, Ghandilyan Y, Gilfoyle GP, Glazier DI, Golubenko AA, Gosta G, Gothe RW, Griffioen KA, Guidal M, Guo L, Hakobyan H, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Ilieva Y, Ireland DG, Isupov EL, Jenkins D, Jo HS, Kabir ML, Khanal A, Khandaker M, Kim A, Kim W, Klein FJ, Kripko A, Kubarovsky V, Lagerquist V, Lanza L, Leali M, Lee S, Lenisa P, Li X, Livingston K, MacGregor IJD, Marchand D, Mascagna V, McKinnon B, McLauchlin C, Meziani ZE, Migliorati S, Mineeva T, Mirazita M, Mokeev V, Munoz Camacho C, Nadel-Turonski P, Neupane K, Niccolai S, Nicol M, Niculescu G, Osipenko M, Ostrovidov AI, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Paul SJ, Phelps W, Pilleux N, Pokhrel M, Poudel J, Price JW, Prok Y, Raue BA, Reed T, Richards J, Ripani M, Ritman J, Rosner G, Sabatié F, Salgado C, Schadmand S, Schmidt A, Schumacher RA, Sharabian YG, Shirokov EV, Shrestha U, Simmerling P, Sokhan D, Sparveris N, Stepanyan S, Strakovsky II, Strauch S, Tan JA, Trotta N, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Voutier E, Wei X, Weinstein LB, Williams R, Wishart R, Wood MH, Yurov M, Zachariou N, Zhao ZW, Zurek M. First Measurement of Λ Electroproduction off Nuclei in the Current and Target Fragmentation Regions. Phys Rev Lett 2023; 130:142301. [PMID: 37084423 DOI: 10.1103/physrevlett.130.142301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Revised: 02/01/2023] [Accepted: 02/24/2023] [Indexed: 05/03/2023]
Abstract
We report results of Λ hyperon production in semi-inclusive deep-inelastic scattering off deuterium, carbon, iron, and lead targets obtained with the CLAS detector and the Continuous Electron Beam Accelerator Facility 5.014 GeV electron beam. These results represent the first measurements of the Λ multiplicity ratio and transverse momentum broadening as a function of the energy fraction (z) in the current and target fragmentation regions. The multiplicity ratio exhibits a strong suppression at high z and an enhancement at low z. The measured transverse momentum broadening is an order of magnitude greater than that seen for light mesons. This indicates that the propagating entity interacts very strongly with the nuclear medium, which suggests that propagation of diquark configurations in the nuclear medium takes place at least part of the time, even at high z. The trends of these results are qualitatively described by the Giessen Boltzmann-Uehling-Uhlenbeck transport model, particularly for the multiplicity ratios. These observations will potentially open a new era of studies of the structure of the nucleon as well as of strange baryons.
Collapse
Affiliation(s)
- T Chetry
- Florida International University, Miami, Florida 33199, USA
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - W K Brooks
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Universidad Técnica Federico Santa María, Casilla, 110-V Valparaíso, Chile
- Center for Science and Technology of Valparaíso, 699 Valparaíso, Chile
- SAPHIR Millennium Science Institute, Santiago, Chile
| | - R Dupré
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla, 110-V Valparaíso, Chile
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Achenbach
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K P Adhikari
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - Z Akbar
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - M Arratia
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | | | - I Bedlinskiy
- National Research Centre Kurchatov Institute - ITEP, Moscow 117259, Russia
| | - B Benkel
- Universidad Técnica Federico Santa María, Casilla, 110-V Valparaíso, Chile
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - A S Biselli
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - W A Booth
- University of York, York YO10 5DD, United Kingdom
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K-Th Brinkmann
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Chesnokov
- Ohio University, Athens, Ohio 45701, USA
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Ciullo
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - P L Cole
- Catholic University of America, Washington, D.C. 20064, USA
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Eugenio
- Florida State University, Tallahassee, Florida 32306, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - G Gavalian
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Gosta
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - L Guo
- Florida International University, Miami, Florida 33199, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla, 110-V Valparaíso, Chile
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Hobart
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - D Jenkins
- Virginia Tech, Blacksburg, Virginia 24061-0435, USA
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - M L Kabir
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - M Khandaker
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - F J Klein
- Catholic University of America, Washington, D.C. 20064, USA
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Lagerquist
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - S Lee
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Lenisa
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - X Li
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - C McLauchlin
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Migliorati
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla, 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Munoz Camacho
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Nicol
- University of York, York YO10 5DD, United Kingdom
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A I Ostrovidov
- Florida State University, Tallahassee, Florida 32306, USA
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - R Paremuzyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S J Paul
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
- The George Washington University, Washington, D.C. 20052, USA
| | - N Pilleux
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Pokhrel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - J Richards
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Institut fur Kernphysik (Juelich), Juelich 52428, Germany
| | - G Rosner
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - S Schadmand
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - R A Schumacher
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E V Shirokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P Simmerling
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- The George Washington University, Washington, D.C. 20052, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - J A Tan
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - N Trotta
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Universit'a degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Universit'e Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L B Weinstein
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - R Williams
- University of York, York YO10 5DD, United Kingdom
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York 14208, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - M Yurov
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Zurek
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
21
|
Goel H, Kumar R, Tanwar P, Upadhyay TK, Khan F, Pandey P, Kang S, Moon M, Choi J, Choi M, Park MN, Kim B, Saeed M. Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia. Biomed Pharmacother 2023; 160:114351. [PMID: 36736284 DOI: 10.1016/j.biopha.2023.114351] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Revised: 01/30/2023] [Accepted: 01/31/2023] [Indexed: 02/04/2023] Open
Abstract
Leukemia is a heterogeneous group of hematological malignancies distinguished by differentiation blockage and uncontrolled proliferation of myeloid or lymphoid progenitor cells in the bone marrow (BM) and peripheral blood (PB). There are various types of leukemia in which intensive chemotherapy regimens or hematopoietic stem cell transplantation (HSCT) are now the most common treatments associated with severe side effects and multi-drug resistance in leukemia cells. Therefore, it is crucial to develop novel therapeutic approaches with adequate therapeutic efficacy and selectively eliminate leukemic cells to improve the consequences of leukemia. Medicinal plants have been utilized for ages to treat multiple disorders due to their diverse bioactive compounds. Plant-derived products have been used as therapeutic medication to prevent and treat many types of cancer. Over the last two decades, 50 % of all anticancer drugs approved worldwide are from natural products and their derivatives. Therefore this study aims to review natural products such as polyphenols, alkaloids, terpenoids, nitrogen-containing, and organosulfur compounds as antileukemic agents. Current investigations have identified natural products efficiently destroy leukemia cells through diverse mechanisms of action by inhibiting proliferation, reactive oxygen species production, inducing cell cycle arrest, and apoptosis in both in vitro, in vivo, and clinical studies. Current investigations have identified natural products as suitable promising chemotherapeutic and chemopreventive agents. It played an essential role in drug development and emerged as a possible source of biologically active metabolites for therapeutic interventions, especially in leukemia. DATA AVAILABILITY: Data will be made available on request.
Collapse
Affiliation(s)
- Harsh Goel
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi 11023, India.
| | - Rahul Kumar
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi 11023, India.
| | - Pranay Tanwar
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi 11023, India.
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India,.
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India.
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India.
| | - Sojin Kang
- Department of Pathology, College of Korean Medicine, Kyung Hee University, 05253, Republic of Korea.
| | - Myunghan Moon
- Department of Pathology, College of Korean Medicine, Kyung Hee University, 05253, Republic of Korea.
| | - Jinwon Choi
- Department of Pathology, College of Korean Medicine, Kyung Hee University, 05253, Republic of Korea.
| | - Min Choi
- Department of Pathology, College of Korean Medicine, Kyung Hee University, 05253, Republic of Korea.
| | - Moon Nyeo Park
- Department of Pathology, College of Korean Medicine, Kyung Hee University, 05253, Republic of Korea.
| | - Bonglee Kim
- Department of Pathology, College of Korean Medicine, Kyung Hee University, 05253, Republic of Korea.
| | - Mohd Saeed
- Department of Biology, College of Sciences, University of Hail, P.O. Box 2440, Hail 81411 Saudi Arabia.
| |
Collapse
|
22
|
Pandey P, Khan F, Alshammari N, Saeed A, Aqil F, Saeed M. Updates on the anticancer potential of garlic organosulfur compounds and their nanoformulations: Plant therapeutics in cancer management. Front Pharmacol 2023; 14:1154034. [PMID: 37021043 PMCID: PMC10067574 DOI: 10.3389/fphar.2023.1154034] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Accepted: 03/02/2023] [Indexed: 03/22/2023] Open
Abstract
Garlic (Allium sativum L.) possesses numerous pharmacological potential, including antibacterial, antiarthritic, antithrombotic, anticancer, hypoglycemic, and hypolipidemic effects. The anti-cancer action of garlic is likely the best researched of the many advantageous pharmacological effects, and its use offers significant protection against the risk of developing cancer. A few active metabolites of garlic have been reported to be essential in the destruction of malignant cells due to their multi-targeted activities and lack of significant toxicity. The bioactive compounds in garlic having anticancer properties include diallyl trisulfide, allicin, allyl mercaptan diallyl disulfide, and diallyl sulphide. Different garlic-derived constituents and their nanoformulations have been tested for their effects against various cancers including skin, ovarian, prostate, gastric, breast, and lung, colorectal, liver, oral, and pancreatic cancer. The objective of this review is to summarize the antitumor activity and associated mechanisms of the organosulfur compounds of garlic in breast carcinoma. Breast cancer continues to have a significant impact on the total number of cancer deaths worldwide. Global measures are required to reduce its growing burden, particularly in developing nations where incidence is increasing quickly and fatality rates are still high. It has been demonstrated that garlic extract, its bioactive compounds, and their use in nanoformulations can prevent breast cancer in all of its stages, including initiation, promotion, and progression. Additionally, these bioactive compounds affect cell signaling for cell cycle arrest and survival along with lipid peroxidation, nitric oxide synthase activity, epidermal growth factor receptor, nuclear factor kappa B (NF-κB), and protein kinase C in breast carcinoma. Hence, this review deciphers the anticancer potential of garlic components and its nanoformulations against several breast cancer thereby projecting it as a potent drug candidate for efficient breast cancer management.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Noida, Uttar Pradesh, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Noida, Uttar Pradesh, India
- *Correspondence: Fahad Khan, ; Mohd Saeed,
| | - Nawaf Alshammari
- Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia
- Molecular Diagnostics and Personalized Therapeutics Unit, University of Hail, Hail, Saudi Arabia
| | - Amir Saeed
- Molecular Diagnostics and Personalized Therapeutics Unit, University of Hail, Hail, Saudi Arabia
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, Hail, Saudi Arabia
| | - Farrukh Aqil
- Department of Medicine and Brown Cancer Center, University of Louisville, Louisville, KY, United States
| | - Mohd Saeed
- Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia
- Molecular Diagnostics and Personalized Therapeutics Unit, University of Hail, Hail, Saudi Arabia
- *Correspondence: Fahad Khan, ; Mohd Saeed,
| |
Collapse
|
23
|
Pandey P, Khan F, Upadhyay TK. Deciphering the modulatory role of apigenin targeting oncogenic pathways in human cancers. Chem Biol Drug Des 2023; 101:1446-1458. [PMID: 36746671 DOI: 10.1111/cbdd.14206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2022] [Revised: 12/14/2022] [Accepted: 02/01/2023] [Indexed: 02/08/2023]
Abstract
Cancer is a complicated malignancy controlled by numerous intrinsic and extrinsic pathways. There has been a significant increase in interest in recent years in the elucidation of cancer treatments based on natural extracts that have fewer side effects. Numerous natural product-derived chemicals have been investigated for their anticancer effects in the search for an efficient chemotherapeutic method. Therefore, the rationale behind this review is to provide a detailed insights about the anticancerous potential of apigenin via modulating numerous cell signaling pathways. An ingestible plant-derived flavonoid called apigenin has been linked to numerous anticancerous potential in numerous experimental and biological studies. Apigenin has been reported to induce cell growth arrest and apoptotic induction by modulating multiple cell signaling pathways in a wider range of human tumors including those of the breast, lung, liver, skin, blood, colon, prostate, pancreatic, cervical, oral, and stomach. Oncogenic protein networks, abnormal cell signaling, and modulation of the apoptotic machinery are only a few examples of diverse molecular interactions and processes that have not yet been thoroughly addressed by scientific research. Thus, keeping this fact in mind, we tried to focus our review towards summarizing the apigenin-mediated modulation of oncogenic pathways in various malignancies that can be further utilized to develop a potent therapeutic alternative for the treatment of various cancers.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, Uttar Pradesh, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, Uttar Pradesh, India
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara, Gujarat, India
| |
Collapse
|
24
|
Pandey P, Khan F, Upadhyay TK, Sharangi AB. Deciphering the Immunomodulatory Role of Cyclin-Dependent Kinase 4/6 Inhibitors in the Tumor Microenvironment. Int J Mol Sci 2023; 24:ijms24032236. [PMID: 36768557 PMCID: PMC9916547 DOI: 10.3390/ijms24032236] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2022] [Revised: 01/18/2023] [Accepted: 01/20/2023] [Indexed: 01/24/2023] Open
Abstract
Cancer is characterized by persistent cell proliferation driven by aberrant cell cycle regulation and stimulation of cyclin-dependent kinases (CDKs). A very intriguing and potential approach for the development of antitumor medicines is the suppression of CDKs that lead to induction of apoptosis and cell cycle arrest. The shift of the cell cycle from the G0/G1 phase to the S phase, which is characterized by active transcription and synthesis, depends on the development of the cyclin D-CDK4/6 complex. A precise balance between anticancer activity and general toxicity is demonstrated by CDK inhibitors, which can specifically block CDK4/6 and control the cell cycle by reducing the G1 to S phase transition. CDK4/6 inhibitors have recently been reported to exhibit significant cell growth inhibition via modulating the tumour microenvironment in cancerous cells. One significant new understanding is that these inhibitors serve important functions in the interaction among tumour cells and the host immune system in addition to being cytostatic. Herein, we discuss the biological significance of CDK4/6 inhibitors in cancer therapeutics, as well as their biological impact on T cells and other important immune cells. Furthermore, we explore the integration of preclinical findings of these pharmaceuticals' ability to enhance antitumor immunity.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida 201306, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida 201306, India
- Correspondence:
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India
| | - Amit Baran Sharangi
- Department of Plantation Spices Medicinal and Aromatic Crops, Bidhan Chandra Krishi Viswavidyalaya, Mohanpur 741252, India
| |
Collapse
|
25
|
Avakian H, Hayward TB, Kotzinian A, Armstrong WR, Atac H, Ayerbe Gayoso C, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benkel B, Benmokhtar F, Bianconi A, Biondo L, Biselli AS, Bondi M, Boiarinov S, Bossù F, Brinkman KT, Briscoe WJ, Brooks WK, Bueltmann S, Bulumulla D, Burkert VD, Capobianco R, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chesnokov V, Chetry T, Ciullo G, Cole PL, Contalbrigo M, Costantini G, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Dilks C, Djalali C, Dupre R, Egiyan H, El Alaoui A, El Fassi L, Elouadrhiri L, Fegan S, Filippi A, Forest T, Gates K, Gavalian G, Ghandilyan Y, Glazier DI, Golubenko AA, Gosta G, Gothe RW, Gotra Y, Griffioen KA, Guidal M, Hakobyan H, Hattawy M, Hauenstein F, Heddle D, Hobart A, Holtrop M, Hyde CE, Ilieva Y, Ireland DG, Isupov EL, Jo HS, Johnston R, Joo K, Kabir ML, Keller D, Khachatryan M, Khanal A, Kim A, Kim W, Klimenko V, Kripko A, Kubarovsky V, Kuhn SE, Lagerquist V, Lanza L, Leali M, Lee S, Lenisa P, Li X, MacGregor IJD, Marchand D, Mascagna V, McKinnon B, Migliorati S, Mineeva T, Mirazita M, Mokeev V, Montgomery RA, Munoz Camacho C, Nadel-Turonski P, Naidoo P, Neupane K, Nguyen D, Niccolai S, Nicol M, Niculescu G, Osipenko M, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Paul SJ, Phelps W, Pilleux N, Pogorelko O, Pokhrel M, Poudel J, Price JW, Prok Y, Raue BA, Reed T, Richards J, Ripani M, Ritman J, Rossi P, Sabatié F, Salgado C, Schmidt A, Sharabian YG, Shirokov EV, Shrestha U, Simmerling P, Sokhan D, Sparveris N, Stepanyan S, Strakovsky II, Strauch S, Tan JA, Trotta N, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Vossen A, Voutier E, Watts DP, Wei X, Wishart R, Wood MH, Zachariou N, Zhao ZW, Zurek M. Observation of Correlations between Spin and Transverse Momenta in Back-to-Back Dihadron Production at CLAS12. Phys Rev Lett 2023; 130:022501. [PMID: 36706384 DOI: 10.1103/physrevlett.130.022501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/10/2022] [Revised: 11/07/2022] [Accepted: 12/07/2022] [Indexed: 06/18/2023]
Abstract
We report the first measurements of deep inelastic scattering spin-dependent azimuthal asymmetries in back-to-back dihadron electroproduction in the deep inelastic scattering process. In this reaction, two hadrons are produced in opposite hemispheres along the z axis in the virtual photon-target nucleon center-of-mass frame, with the first hadron produced in the current-fragmentation region and the second in the target-fragmentation region. The data were taken with longitudinally polarized electron beams of 10.2 and 10.6 GeV incident on an unpolarized liquid-hydrogen target using the CLAS12 spectrometer at Jefferson Lab. Observed nonzero sinΔϕ modulations in ep→e^{'}pπ^{+}X events, where Δϕ is the difference of the azimuthal angles of the proton and pion in the virtual photon and target nucleon center-of-mass frame, indicate that correlations between the spin and transverse momenta of hadrons produced in the target- and current-fragmentation regions may be significant. The measured beam-spin asymmetries provide a first access in dihadron production to a previously unexplored leading-twist spin- and transverse-momentum-dependent fracture function. The fracture functions describe the hadronization of the target remnant after the hard scattering of a virtual photon off a quark in the target particle and provide a new avenue for studying nucleonic structure and hadronization.
Collapse
Affiliation(s)
- H Avakian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Kotzinian
- Yerevan Physics Institute, 375036 Yerevan, Armenia
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - C Ayerbe Gayoso
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | | | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow 117259, Russia
| | - B Benkel
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - L Biondo
- INFN, Sezione di Genova, 16146 Genova, Italy
- INFN, Sezione di Catania, 95123 Catania, Italy
- Università degli Studi di Messina, 98166 Messina, Italy
| | - A S Biselli
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - K T Brinkman
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - W K Brooks
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - S Bueltmann
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Capobianco
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Chesnokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - T Chetry
- Florida International University, Miami, Florida 33199, USA
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
- Ohio University, Athens, Ohio 45701, USA
| | - G Ciullo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Università di Ferrara, 44121 Ferrara, Italy
| | - P L Cole
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
| | | | - G Costantini
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - C Dilks
- Duke University, Durham, North Carolina 27708-0305, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
| | - R Dupre
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - T Forest
- Idaho State University, Pocatello, Idaho 83209, USA
| | - K Gates
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - G Gavalian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Gosta
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Y Gotra
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - F Hauenstein
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D Heddle
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - C E Hyde
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - R Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M L Kabir
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - M Khachatryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - V Klimenko
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - A Kripko
- II. Physikalisches Institut der Universität Gießen, 35392 Gießen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V Lagerquist
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - S Lee
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - P Lenisa
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Università di Ferrara, 44121 Ferrara, Italy
| | - X Li
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - S Migliorati
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Naidoo
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D Nguyen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Nicol
- University of York, York YO10 5DD, United Kingdom
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- Temple University, Philadelphia, Pennsylvania 19122, USA
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
- Università di Ferrara, 44121 Ferrara, Italy
| | - R Paremuzyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S J Paul
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - W Phelps
- The George Washington University, Washington, D.C. 20052, USA
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - N Pilleux
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow 117259, Russia
| | - M Pokhrel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - J Richards
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- GSI Helmholtzzentrum fur Schwerionenforschung GmbH, D-64291 Darmstadt, Germany
- Institute fur Kernphysik (Juelich), 52428 Juelich, Germany
| | - P Rossi
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E V Shirokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P Simmerling
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - J A Tan
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - N Trotta
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- Università degli Studi di Brescia, 25123 Brescia, Italy
- INFN, Sezione di Pavia, 27100 Pavia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - A Vossen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Duke University, Durham, North Carolina 27708-0305, USA
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York 14208, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
| | - M Zurek
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
26
|
Thaman J, Pal RS, Chaitanya MVNL, Yanadaiah P, Thangavelu P, Sharma S, Amoateng P, Arora S, Sivasankaran P, Pandey P, Mazumder A. Reconciling the Gap between Medications and their Potential Leads: The Role of Marine Metabolites in the Discovery of New Anticancer Drugs: A Comprehensive Review. Curr Pharm Des 2023; 29:3137-3153. [PMID: 38031774 DOI: 10.2174/0113816128272025231106071447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Revised: 10/12/2023] [Accepted: 10/13/2023] [Indexed: 12/01/2023]
Abstract
One-third of people will be diagnosed with cancer at some point in their lives, making it the second leading cause of death globally each year after cardiovascular disease. The complex anticancer molecular mechanisms have been understood clearly with the advent of improved genomic, proteomic, and bioinformatics. Our understanding of the complex interplay between numerous genes and regulatory genetic components within cells explaining how this might lead to malignant phenotypes has greatly expanded. It was discovered that epigenetic resistance and a lack of multitargeting drugs were highlighted as major barriers to cancer treatment, spurring the search for innovative anticancer treatments. It was discovered that epigenetic resistance and a lack of multitargeting drugs were highlighted as major barriers to cancer treatment, spurring the search for innovative anticancer treatments. Many popular anticancer drugs, including irinotecan, vincristine, etoposide, and paclitaxel, have botanical origins. Actinomycin D and mitomycin C come from bacteria, while bleomycin and curacin come from marine creatures. However, there is a lack of research evaluating the potential of algae-based anticancer treatments, especially in terms of their molecular mechanisms. Despite increasing interest in the former, and the promise of the compounds to treat tumours that have been resistant to existing treatment, pharmaceutical development of these compounds has lagged. Thus, the current review focuses on the key algal sources that have been exploited as anticancer therapeutic leads, including their biological origins, phytochemistry, and the challenges involved in converting such leads into effective anticancer drugs.
Collapse
Affiliation(s)
- Janvee Thaman
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144402, India
| | - Rashmi Saxena Pal
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144402, India
| | | | - Palakurthi Yanadaiah
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144402, India
| | - Prabha Thangavelu
- Department of Pharmaceutical Chemistry, Nandha College of Pharmacy, Affiliated to The Tamil Nadu Dr. MGR Medical University, Erode 638052, Tamil Nadu, India
| | - Sarika Sharma
- Department of Sponsored Research, Division of Research & Development, Lovely Professional University, Phagwara 144402, India
| | - Patrick Amoateng
- Department of Pharmacology & Toxicology, School of Pharmacy, University of Ghana, Legon, Accra, Ghana
| | - Smriti Arora
- Department of Biotechnology, School of Allied Health Sciences, University of Petroleum & Energy Studies (UPES), Bidholi, Dehradun 248007, India
| | - Ponnusankar Sivasankaran
- Department of Pharmacy Practice, JSS College of Pharmacy (JSS Academy of Higher Education and Research), Rocklands, Ooty 643001, Tamil Nadu, India
| | - Pratibha Pandey
- Department of Life Sciences, Noida Institute of Engineering & Technology, Gautam Buddh Nagar, 19, Knowledge Park-II, 22, Institutional Area, Greater Noida 201306, India
| | - Avijit Mazumder
- School of Pharmacy, Niet Pharmacy Institute c Block, Noida Institute of Engineering & Technology (Pharmacy Institute), 24 Gautam Buddh Nagar, 19, Knowledge Park-II, Institutional Area, Greater Noida 201306, India
| |
Collapse
|
27
|
Pandey P, Khan F, Maqsood R, Upadhyay TK. Current Perspectives on Nanoparticle-based Targeted Drug Delivery Approaches in Breast Cancer Treatment. Endocr Metab Immune Disord Drug Targets 2023; 23:1291-1302. [PMID: 36924095 DOI: 10.2174/1871530323666230315145332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/15/2022] [Revised: 01/25/2023] [Accepted: 01/26/2023] [Indexed: 03/18/2023]
Abstract
Breast cancer is avertible yet one of the most widespread carcinomas globally. Though periodic screening and monitoring have resulted in reduced incidences, the malignancy claims increased death rates across the globe. Due to the non-specific and aggressive nature of available conventional cancer therapeutics, there is a crucial need for better treatment paradigms. Recent advancements in nanotechnology have aided in this by utilizing nanocarriers in targeted drug delivery approaches. Optimized nanoparticles have been used to enhance the circulation time and target the efficacy of conventional therapeutic drugs. Passive targeting comprises surface modulation to avoid drug elimination via a standard body defense system. Active targeting includes chemical interaction with various genes, receptors, and antigens overexpressed during cancer progression. Therefore, the present review recapitulates drug delivery approaches and nanoparticle-based targeting that can potentially overcome the limitations of conventional drug therapies.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India
| | - Ramish Maqsood
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara, 391760, India
| |
Collapse
|
28
|
Goel H, Goyal K, Pandey AK, Benjamin M, Khan F, Pandey P, Mittan S, Iqbal D, Alsaweed M, Alturaiki W, Madkhali Y, Kamal MA, Tanwar P, Upadhyay TK. Elucidations of Molecular Mechanism and Mechanistic Effects of Environmental Toxicants in Neurological Disorders. CNS Neurol Disord Drug Targets 2023; 22:84-97. [PMID: 35352654 DOI: 10.2174/1871527321666220329103610] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/11/2021] [Revised: 02/08/2022] [Accepted: 02/08/2022] [Indexed: 02/08/2023]
Abstract
Due to rising environmental and global public health concerns associated with environmental contamination, human populations are continually being exposed to environmental toxicants, including physical chemical mutagens widespread in our environment causing adverse consequences and inducing a variety of neurological disorders in humans. Physical mutagens comprise ionizing and non-ionizing radiation, such as UV rays, IR rays, X-rays, which produces a broad spectrum of neuronal destruction, including neuroinflammation, genetic instability, enhanced oxidative stress driving mitochondrial damage in the human neuronal antecedent cells, cognitive impairment due to alterations in neuronal function, especially in synaptic plasticity, neurogenesis repression, modifications in mature neuronal networks drives to enhanced neurodegenerative risk. Chemical Mutagens including alkylating agents (EMS, NM, MMS, and NTG), Hydroxylamine, nitrous acid, sodium azide, halouracils are the major toxic mutagen in our environment and have been associated with neurological disorders. These chemical mutagens create dimers of pyrimidine that cause DNA damage that leads to ROS generation producing mutations, chromosomal abnormalities, genotoxicity which leads to increased neurodegenerative risk. The toxicity of four heavy metal including Cd, As, Pb, Hg is mostly responsible for complicated neurological disorders in humans. Cadmium exposure can enhance the permeability of the BBB and penetrate the brain, driving brain intracellular accumulation, cellular dysfunction, and cerebral edema. Arsenic exerts its toxic effect by induction of ROS production in neuronal cells. In this review, we summarize the molecular mechanism and mechanistic effects of mutagens in the environment and their role in multiple neurological disorders.
Collapse
Affiliation(s)
- Harsh Goel
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, India
| | - Keshav Goyal
- Division of Molecular and Cellular Biology, Faculty of Biology, Ludwig Maximilians Universitat, Munchen, Germany
| | - Avanish Kumar Pandey
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, India
| | - Mercilena Benjamin
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, India
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, India
| | - Sandeep Mittan
- Department of Cardiology, Ichan School of Medicine, Mount Sinai Hospital, One Gustave L. Levy Place, New York, USA
| | - Danish Iqbal
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al-Majmaah, 11952, Saudi Arabia
| | - Mohammed Alsaweed
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al-Majmaah, 11952, Saudi Arabia
| | - Wael Alturaiki
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al-Majmaah, 11952, Saudi Arabia
| | - Yahya Madkhali
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al-Majmaah, 11952, Saudi Arabia
| | - Mohammad Amjad Kamal
- Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, China
- King Fahd Medical Research Center, King Abdulaziz University, Saudi Arabia
- Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Bangladesh
- Enzymoics, 7 Peterlee Place, Hebersham NSW 2770, Novel Global Community Educational Foundation, Australia
| | - Pranay Tanwar
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, India
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Cell Culture and Immunobiochemistry Lab, Centre of Research for Development, Parul University, Vadodara, Gujarat 391760, India
| |
Collapse
|
29
|
Khan F, Pandey P, Singh A, Upadhyay TK, AboElnaga SMH, Al-Najjar MAA, Saeed M, Kahrizi D. Unveiling Antioxidant and Antiproliferative Effects of Prosopis juliflora Leaves against Human Prostate Cancer LNCaP Cells. Cell Mol Biol (Noisy-le-grand) 2022; 68:20-27. [PMID: 37114313 DOI: 10.14715/cmb/2022.68.11.4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Indexed: 04/29/2023]
Abstract
Herbal medications or formulations are regularly recommended by clinicians as a potential therapeutic method for a variety of human ailments, including cancer. Although Prosopis juliflora extracts have shown promise in anticancer activity, the effects on prostate cancer and the accompanying molecular mechanisms of action are still unexplored. This research aims at the antioxidant, antiproliferative, and apoptosis-inducing properties of Prosopis juliflora methanolic leaves extract in human prostate cancer LNCaP cells. The antioxidant ability of the extract was assessed using the DPPH (2, 2-diphenyl-2-picrylhydrazyl) and two additional reducing power tests. Antitumor activity was determined using MTT cell viability tests and LDH cytotoxicity assays. The probable mechanism of apoptotic cell death was further investigated utilizing a caspase-3 activation assay and qRT-PCR mRNA expression investigations of apoptotic-related genes. The results revealed that the methanol extract of Prosopis juliflora leaves contains alkaloids, flavonoids, tannins, glycosides, and phenols, all of which have substantial antioxidant activity. In vitro anticancer tests demonstrated that extract therapy resulted in a dose-dependent reduction in cell viability of LNCaP prostate cancer cells, but normal HaCaT cells showed no cytotoxic effects. Furthermore, plant extract therapy increased caspase-3 activation and mRNA expression of apoptotic-related genes, suggesting that this could be a mechanism for cancer cell growth suppression. The significance of Prosopis juliflora as a source of new antioxidant compounds against prostate cancer was emphasized in the current study. However, more study is needed to demonstrate the efficacy of Prosopis juliflora leaves extract in the treatment of prostate cancer.
Collapse
Affiliation(s)
- Fahad Khan
- Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, 201306, India.
| | - Pratibha Pandey
- Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, 201306, India.
| | - Aashi Singh
- Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, 201306, India.
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara, Gujarat, 391760, India.
| | | | - Mohammad A A Al-Najjar
- Department of pharmaceutical sciences and pharmaceutics. Faculty of pharmacy. Applied Science Private University, Amman, Jordan.
| | - Mohd Saeed
- Department of Biology, College of Sciences, University of Hail, PO BOX 2240, Hail, Saudi Arabia.
| | - Danial Kahrizi
- Agricultural Biotechnology Department, Faculty of Agriculture, Tarbiat Modares University, Tehran, Iran.
| |
Collapse
|
30
|
Pandey P, Khan F, Chauhan P, Upadhyay TK, Bardakci F, Alam MJ, Almuzaini N, Abdalla RAH, Singh SK, Saeed M. Elucidation of the inhibitory potential of flavonoids against PKP1 protein in non-small cell lung cancer. Cell Mol Biol (Noisy-le-grand) 2022; 68:90-96. [PMID: 37114302 DOI: 10.14715/cmb/2022.68.11.15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Indexed: 04/29/2023]
Abstract
PKP1 has been crucially involved in enhancing the MYC translation leading to lung carcinogenesis via evading numerous tumour-suppressing checkpoint systems. Plakophilin 1(PKP1) is the part of armadillo and plakophilin gene families and it is a necessary component of desmosomes. Several researches reported PKP1 protein as one of the most overexpressed proteins in human lung cancer. Therefore, we have designed our research towards elucidating better plant-based compounds as drug candidates for the management of lung cancer with minimal adverse effects over other chemotherapeutic drugs such as afatinib. This study comprises forty-six flavonoids for targeting PKP1 using in silico approaches that were not used earlier as an anti-cancerous agent targeting PKP1 in lung cancer treatment. Flavonoids are plant-derived natural compounds that exhibited enormous anti-cancerous potential against several human cancers. NPACT database was used to screen potent flavonoids that have not been used to target the PKP1 protein in lung cancer. Patch Dock and CB Dock were employed to elucidate the PKP1 (1XM9) inhibitory potential of selected flavonoids. Analysis with both the docking tools has revealed that calyxins I showed maximum affinity in comparison to the standard drug, afatinib. Further PASS and BAS analyses were performed using SWISS ADME and molinspiration to investigate the pharmacokinetic profiling of potent flavonoids having significant binding energy. Visualization of complexes was done by using UCSF chimera. However, further detailed in vitro studies are needed to validate the candidature of calyxinsI for being developed as an anticancer drug for the management of lung cancer.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India.
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India.
| | - Prashant Chauhan
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India.
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India.
| | - Fevzi Bardakci
- Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia.
| | - Md Jahoor Alam
- Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia.
| | - Nujud Almuzaini
- Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia.
| | | | - Sujeet Kumar Singh
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India.
| | - Mohd Saeed
- Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia.
| |
Collapse
|
31
|
Mujahid MH, Upadhyay TK, Khan F, Pandey P, Park MN, Sharangi AB, Saeed M, Upadhye VJ, Kim B. Metallic and metal oxide-derived nanohybrid as a tool for biomedical applications. Biomed Pharmacother 2022; 155:113791. [DOI: 10.1016/j.biopha.2022.113791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2022] [Revised: 09/29/2022] [Accepted: 10/02/2022] [Indexed: 11/02/2022] Open
|
32
|
Paul SJ, Morán S, Arratia M, El Alaoui A, Hakobyan H, Brooks W, Amaryan MJ, Armstrong WR, Atac H, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benkel B, Benmokhtar F, Bianconi A, Biondo L, Biselli AS, Bondi M, Bossù F, Boiarinov S, Brinkmann KT, Briscoe WJ, Bulumulla D, Burkert VD, Capobianco R, Carman DS, Celentano A, Chesnokov V, Chetry T, Ciullo G, Cole PL, Contalbrigo M, Costantini G, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Dilks C, Djalali C, Dupre R, Egiyan H, El Fassi L, Eugenio P, Fegan S, Filippi A, Gavalian G, Ghandilyan Y, Gilfoyle GP, Golubenko AA, Gosta G, Gothe RW, Griffioen KA, Guidal M, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Ilieva Y, Ireland DG, Isupov EL, Jo HS, Johnston R, Joo K, Joosten S, Keller D, Khanal A, Khandaker M, Kim W, Kripko A, Kubarovsky V, Lagerquist V, Lanza L, Leali M, Lee S, Lenisa P, Li X, Livingston K, MacGregor IJD, Marchand D, Mascagna V, McKinnon B, Meziani ZE, Migliorati S, Milner RG, Mineeva T, Mirazita M, Mokeev VI, Moran P, Munoz Camacho C, Neupane K, Nguyen D, Niccolai S, Niculescu G, Osipenko M, Ostrovidov AI, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Phelps W, Pilleux N, Pocanic D, Pogorelko O, Pokhrel M, Poudel J, Price JW, Prok Y, Raue BA, Reed T, Ripani M, Rosner G, Sabatié F, Salgado C, Schmidt A, Schumacher RA, Sharabian YG, Shirokov EV, Shrestha U, Simmerling P, Sokhan D, Sparveris N, Stepanyan S, Strakovsky II, Strauch S, Tan JA, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Voutier E, Wei X, Wishart R, Wood MH, Zachariou N, Zhao ZW, Ziegler V, Zurek M. Observation of Azimuth-Dependent Suppression of Hadron Pairs in Electron Scattering off Nuclei. Phys Rev Lett 2022; 129:182501. [PMID: 36374671 DOI: 10.1103/physrevlett.129.182501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/19/2022] [Revised: 08/26/2022] [Accepted: 09/30/2022] [Indexed: 06/16/2023]
Abstract
We present the first measurement of dihadron angular correlations in electron-nucleus scattering. The data were taken with the CLAS detector and a 5.0 GeV electron beam incident on deuterium, carbon, iron, and lead targets. Relative to deuterium, the nuclear yields of charged-pion pairs show a strong suppression for azimuthally opposite pairs, no suppression for azimuthally nearby pairs, and an enhancement of pairs with large invariant mass. These effects grow with increased nuclear size. The data are qualitatively described by the gibuu model, which suggests that hadrons form near the nuclear surface and undergo multiple scattering in nuclei.These results show that angular correlation studies can open a new way to elucidate how hadrons form and interact inside nuclei.
Collapse
Affiliation(s)
- S J Paul
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - S Morán
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - M Arratia
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- University of California Riverside, 900 University Avenue, Riverside, California 92521, USA
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - W Brooks
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M J Amaryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | | | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - B Benkel
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - L Biondo
- INFN, Sezione di Genova, 16146 Genova, Italy
- INFN, Sezione di Catania, 95123 Catania, Italy
- Università degli Studi di Messina, 98166 Messina, Italy
| | - A S Biselli
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K-Th Brinkmann
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Capobianco
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - V Chesnokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - T Chetry
- Florida International University, Miami, Florida 33199, USA
| | - G Ciullo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - P L Cole
- Catholic University of America, Washington, D.C. 20064, USA
- Lamar University, 4400 MLK Blvd, P.O. Box 10046, Beaumont, Texas 77710, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - C Dilks
- Duke University, Durham, North Carolina 27708-0305, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Dupre
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - P Eugenio
- Florida State University, Tallahassee, Florida 32306, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - G Gavalian
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - G Gosta
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - Y Ilieva
- The George Washington University, Washington, D.C. 20052, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - R Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - S Joosten
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - M Khandaker
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Lagerquist
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - S Lee
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - P Lenisa
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - X Li
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Migliorati
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - R G Milner
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - T Mineeva
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V I Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Moran
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D Nguyen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A I Ostrovidov
- Florida State University, Tallahassee, Florida 32306, USA
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- New Mexico State University, PO Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - R Paremuzyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - N Pilleux
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D Pocanic
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - M Pokhrel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - G Rosner
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
| | - R A Schumacher
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E V Shirokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - P Simmerling
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- The George Washington University, Washington, D.C. 20052, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - J A Tan
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Rensselaer Polytechnic Institute, Troy, New York 12180-3590, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York 14208, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
| | - V Ziegler
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Zurek
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
33
|
Sharma R, Pandey P, Srivastava A, Pasbola K, Saraya A, Dash N. 65P MicroRNA profiles associated with response to neoadjuvant chemotherapy in esophageal cancer patients. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.09.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
34
|
Mishra R, Pandey P, Khan F. Unravelling the Influence of Nutrition and Mental Stress on Immune Response. Endocr Metab Immune Disord Drug Targets 2022; 23:423-427. [PMID: 36173043 DOI: 10.2174/1871530322666220928143601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2021] [Revised: 07/26/2022] [Accepted: 08/03/2022] [Indexed: 11/22/2022]
Abstract
The review comprises of a study which reveals the role of mental as well as biological phenomenon working behind immunity. In the recent time, irresistible illnesses and inflammation was thought, to be result of the hereditary legacy or the natural working of the human body, during the pathogenic variables working inside the human system. In past few years, importance of psychological adjust, mental wellbeing and eating habits has been studied and shown to have marked effect on the immunity. Psychoneuroimmunology considers that passionate designs and the mental elements are strongly interrelated with the resistant reaction. Besides, the immunological components control he wellbeing of the individual. Psychosocial mediations recommend increased productivity in diminishing aggravation and moving forward immune framework work. The nutrition plays a vital role in regard to immunity and so our mental health or vice versa in case of immunity and mental health.
Collapse
Affiliation(s)
- Rashmi Mishra
- Department of Biotechnology, Noida Institute of Engineering & Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, 201306, India
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, 201306, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, 201306, India
| |
Collapse
|
35
|
Bal S, Sharangi AB, Upadhyay TK, Khan F, Pandey P, Siddiqui S, Saeed M, Lee HJ, Yadav DK. Biomedical and Antioxidant Potentialities in Chilli: Perspectives and Way Forward. Molecules 2022; 27:molecules27196380. [PMID: 36234927 PMCID: PMC9570844 DOI: 10.3390/molecules27196380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Revised: 09/17/2022] [Accepted: 09/20/2022] [Indexed: 11/16/2022] Open
Abstract
Worldwide, since ages and nowadays, traditional medicine is well known, owing to its biodiversity, which immensely contributed to the advancement and development of complementary and alternative medicines. There is a wide range of spices, herbs, and trees known for their medicinal uses. Chilli peppers, a vegetable cum spice crop, are bestowed with natural bioactive compounds, flavonoids, capsaicinoids, phytochemicals, phytonutrients, and pharmacologically active compounds with potential health benefits. Such compounds manifest their functionality over solo-treatment by operating in synergy and consortium. Co-action of these compounds and nutrients make them potentially effective against coagulation, obesity, diabetes, inflammation, dreadful diseases, such as cancer, and microbial diseases, alongside having good anti-oxidants with scavenging ability to free radicals and oxygen. In recent times, capsaicinoids especially capsaicin can ameliorate important viral diseases, such as SARS-CoV-2. In addition, capsaicin provides an ability to chilli peppers to ramify as topical agents in pain-relief and also benefitting man as a potential effective anesthetic agent. Such phytochemicals involved not only make them useful and a much economical substitute to wonder/artificial drugs but can be exploited as obscene drugs for the production of novel stuffs. The responsibility of the TRPV1 receptor in association with capsaicin in mitigating chronic diseases has also been justified in this study. Nonetheless, medicinal studies pertaining to consumption of chilli peppers are limited and demand confirmation of the findings from animal studies. In this artifact, an effort has been made to address in an accessible format the nutritional and biomedical perspectives of chilli pepper, which could precisely upgrade and enrich our pharmaceutical industries towards human well-being.
Collapse
Affiliation(s)
- Solanki Bal
- Department of Vegetable Science, BCKV-Agricultural University, Mohanpur 741252, India
| | - Amit Baran Sharangi
- Department of Plantation, Spices, Medicinal & Aromatic Crops, BCKV-Agricultural University, Mohanpur 741252, India
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India
- Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida 201310, India
| | - Samra Siddiqui
- Department Health Services Management, College of Public Health and Health Informatics, University of Hail, Hail P.O. Box 2240, Saudi Arabia
| | - Mohd Saeed
- Department of Biology, College of Sciences, University of Hail, Hail P.O. Box 2240, Saudi Arabia
| | - Hae-Jeung Lee
- Department of Food & Nutrition, College of Bionano Technology, Gachon University, 1342 Seongnamdaero, Seongnam-si 13120, Korea
- Correspondence: (H.-J.L.); (D.K.Y.)
| | - Dharmendra K. Yadav
- Department of Pharmacy, Gachon Institute of Pharmaceutical Science, College of Pharmacy, Hambakmoeiro 191, Gachon University, Incheon 21924, Korea
- Correspondence: (H.-J.L.); (D.K.Y.)
| |
Collapse
|
36
|
Goyal K, Goel H, Baranwal P, Dixit A, Khan F, Jha NK, Kesari KK, Pandey P, Pandey A, Benjamin M, Maurya A, Yadav V, Sinh RS, Tanwar P, Upadhyay TK, Mittan S. Unravelling the molecular mechanism of mutagenic factors impacting human health. Environ Sci Pollut Res Int 2022; 29:61993-62013. [PMID: 34410595 DOI: 10.1007/s11356-021-15442-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Accepted: 07/09/2021] [Indexed: 06/13/2023]
Abstract
Environmental mutagens are chemical and physical substances in the environment that has a potential to induce a wide range of mutations and generate multiple physiological, biochemical, and genetic modifications in humans. Most mutagens are having genotoxic effects on the following generation through germ cells. The influence of germinal mutations on health will be determined by their frequency, nature, and the mechanisms that keep a specific mutation in the population. Early prenatal lethal mutations have less public health consequences than genetic illnesses linked with long-term medical and social difficulties. Physical and chemical mutagens are common mutagens found in the environment. These two environmental mutagens have been associated with multiple neurological disorders and carcinogenesis in humans. Thus in this study, we aim to unravel the molecular mechanism of physical mutagens (UV rays, X-rays, gamma rays), chemical mutagens (dimethyl sulfate (DMS), bisphenol A (BPA), polycyclic aromatic hydrocarbons (PAHs), 5-chlorocytosine (5ClC)), and several heavy metals (Ar, Pb, Al, Hg, Cd, Cr) implicated in DNA damage, carcinogenesis, chromosomal abnormalities, and oxidative stress which leads to multiple disorders and impacting human health. Biological tests for mutagen detection are crucial; therefore, we also discuss several approaches (Ames test and Mutatox test) to estimate mutagenic factors in the environment. The potential risks of environmental mutagens impacting humans require a deeper basic knowledge of human genetics as well as ongoing research on humans, animals, and their tissues and fluids.
Collapse
Affiliation(s)
- Keshav Goyal
- Department of Microbiology, Ram Lal Anand College, University of Delhi, New Delhi, India
| | - Harsh Goel
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, India
| | - Pritika Baranwal
- Department of Microbiology, Ram Lal Anand College, University of Delhi, New Delhi, India
| | - Aman Dixit
- Department of Microbiology, Ram Lal Anand College, University of Delhi, New Delhi, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, 201306, India
| | - Niraj Kumar Jha
- Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, India
| | | | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida, 201306, India
| | - Avanish Pandey
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, India
| | - Mercilena Benjamin
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, India
| | - Ankit Maurya
- Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India
| | - Vandana Yadav
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
| | - Rana Suryauday Sinh
- Department of Microbiology and Biotechnology Centre, Maharaja Sayajirao University, Baroda, India
| | - Pranay Tanwar
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi, India
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences & Centre of Research for Development, Parul University, Vadodara, Gujarat, India.
| | - Sandeep Mittan
- Department of Cardiology, Ichan School of Medicine, Mount Sinai Hospital, 1 Gustave L. Levy Place, New York, NY, USA
| |
Collapse
|
37
|
Shelke N, Chaudhury S, Chakrabarti S, Bangare SL, Yogapriya G, Pandey P. An efficient way of text-based emotion analysis from social media using LRA-DNN. Neuroscience Informatics 2022; 2:100048. [DOI: 10.1016/j.neuri.2022.100048] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/19/2023]
|
38
|
Upadhyay TK, Trivedi R, Khan F, Pandey P, Sharangi AB, Goel H, Saeed M, Park MN, Kim B. Potential Therapeutic Role of Mesenchymal-Derived Stem Cells as an Alternative Therapy to Combat COVID-19 through Cytokines Storm. Cells 2022; 11:cells11172686. [PMID: 36078094 PMCID: PMC9455060 DOI: 10.3390/cells11172686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2022] [Revised: 08/20/2022] [Accepted: 08/25/2022] [Indexed: 01/08/2023] Open
Abstract
Medical health systems continue to be challenged due to newly emerging COVID-19, and there is an urgent need for alternative approaches for treatment. An increasing number of clinical observations indicate cytokine storms to be associated with COVID-19 severity and also to be a significant cause of death among COVID-19 patients. Cytokine storm involves the extensive proliferative and hyperactive activity of T and macrophage cells and the overproduction of pro-inflammatory cytokines. Stem cells are the type of cell having self-renewal properties and giving rise to differentiated cells. Currently, stem cell therapy is an exciting and promising therapeutic approach that can treat several diseases that were considered incurable in the past. It may be possible to develop novel methods to treat various diseases by identifying stem cells’ growth and differentiation factors. Treatment with mesenchymal stem cells (MSCs) in medicine is anticipated to be highly effective. The present review article is organized to put forward the positive arguments and implications in support of mesenchymal stem cell therapy as an alternative therapy to cytokine storms, to combat COVID-19. Using the immunomodulatory potential of the MSCs, it is possible to fight against COVID-19 and counterbalance the cytokine storm.
Collapse
Affiliation(s)
- Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Animal Cell Culture and Immunobiochemistry Lab, Centre of Research for Development, Parul University, Vadodara 391760, India
- Correspondence: (T.K.U.); (B.K.)
| | - Rashmi Trivedi
- Department of Biotechnology, Parul Institute of Applied Sciences and Animal Cell Culture and Immunobiochemistry Lab, Centre of Research for Development, Parul University, Vadodara 391760, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida 201306, India
| | - Amit Baran Sharangi
- Department of Plantation, Spices, Medicinal & Aromatic Crops, BCKV-Agricultural University, Mohanpur 741252, India
| | - Harsh Goel
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi 110023, India
| | - Mohd Saeed
- Department of Biology, College of Sciences, University of Hail, Hail 34464, Saudi Arabia
| | - Moon Nyeo Park
- Department of Korean Medicine, Kyung Hee University, Seoul 05254, Korea
| | - Bonglee Kim
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea
- Correspondence: (T.K.U.); (B.K.)
| |
Collapse
|
39
|
Upadhyay TK, Trivedi R, Khan F, Al-Keridis LA, Pandey P, Sharangi AB, Alshammari N, Abdullah NM, Yadav DK, Saeed M. In vitro elucidation of antioxidant, antiproliferative, and apoptotic potential of yeast-derived β-1,3-glucan particles against cervical cancer cells. Front Oncol 2022; 12:942075. [PMID: 36059639 PMCID: PMC9436396 DOI: 10.3389/fonc.2022.942075] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2022] [Accepted: 07/12/2022] [Indexed: 11/24/2022] Open
Abstract
Cancer is the leading cause of mortality worldwide and in particular is the fourth most common cause of mortality in women every year. Conventional treatments for cancer are chemotherapy and radiation therapy, which have various kinds of side effects. Hence, there is a high need to develop alternative, efficient, and safer therapies for cancer treatment. β-Glucan, a novel polysaccharide isolated from baker’s yeast Saccharomyces cerevisiae, shows noteworthy cytotoxicity toward a variety of cancer cell lines in vitro. In this research, we characterized the β-glucan with high-performance thin-layer chromatography (HPTLC) analysis and found that d-glucose units with β-1,3 links are the major component of the extracted β-glucan particles. Fourier transform IR (FTIR) analysis confirmed a β-(1→3)-linked glucan structure. In vitro cell cytotoxicity was evaluated by MTT with IC50 136 μg/ml, and therapeutic potential was assessed by various assays using values below and above the IC50. A significant reactive oxygen species (ROS) generation at 50–150 μg/ml of concentrations indicated the apoptosis of cervical cancer cells. Along with ROS generation, these concentrations were also found to induce morphological changes such as fragmentation in DNA upon staining HeLa cells with DAPI. Mitochondrial membrane potential was significantly reduced after increasing the dose of treatment, assessed with the help of MitoTracker dye. Hence, by all these experimental supports, we observed that β-glucan has the potential to slow down the growth of cervical cancer cells, and it can be further investigated for unfolding its complete anticancer potential.
Collapse
Affiliation(s)
- Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara, India
- *Correspondence: Mohd Saeed, ; Dharmendra Kumar Yadav, ; Tarun Kumar Upadhyay, ; Lamya Ahmed Al-Keridis,
| | - Rashmi Trivedi
- Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara, India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, India
| | - Lamya Ahmed Al-Keridis
- Biology Department, Faculty of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia
- *Correspondence: Mohd Saeed, ; Dharmendra Kumar Yadav, ; Tarun Kumar Upadhyay, ; Lamya Ahmed Al-Keridis,
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, India
| | - Amit Baran Sharangi
- Department of Plantation, Spices, Medicinal and Aromatic Crops, Bidhan Chandra Krishi Viswavidyalaya (BCKV)-Agricultural University, Mohanpur, India
| | - Nawaf Alshammari
- Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia
| | - Nadiya M. Abdullah
- Department of Biology, College of Science, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
| | - Dharmendra Kumar Yadav
- Department of Pharmacy and Gachon Institute of Pharmaceutical Science, College of Pharmacy, Gachon University, Yeonsu-gu, Incheon, South Korea
- *Correspondence: Mohd Saeed, ; Dharmendra Kumar Yadav, ; Tarun Kumar Upadhyay, ; Lamya Ahmed Al-Keridis,
| | - Mohd Saeed
- Department of Biology, College of Sciences, University of Hail, Hail, Saudi Arabia
- *Correspondence: Mohd Saeed, ; Dharmendra Kumar Yadav, ; Tarun Kumar Upadhyay, ; Lamya Ahmed Al-Keridis,
| |
Collapse
|
40
|
Pandey P, Khan F, Qari HA, Upadhyay TK, Alkhateeb AF, Oves M. Evidence of Metallic and Polyether Ionophores as Potent Therapeutic Drug Candidate in Cancer Management. Molecules 2022; 27:4708. [PMID: 35897885 PMCID: PMC9329979 DOI: 10.3390/molecules27154708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2022] [Revised: 07/18/2022] [Accepted: 07/20/2022] [Indexed: 02/04/2023] Open
Abstract
Cancer remains one of the most crucial human malignancies with a higher mortality rate globally, and is predicted to escalate soon. Dysregulated ion homeostasis in cancerous cells prompted the researchers to investigate further ion homeostasis impeding agents as potent anticancerous agents. Reutilization of FDA-approved non-cancerous drugs has emerged as a practical approach to developing potent, cost-effective drugs for cancer treatment. Across the globe, most nations are incapable of fulfilling the medical demands of cancer patients due to costlier cancerous drugs. Therefore, we have inclined our review towards emphasizing recent advancements in cancer therapies involving ionophores utilization in exploring potent anticancer drugs. Numerous research reports have established the significant anticancerous potential of ionophores in several pre-clinical reports via modulating aberrant cell signaling pathways and enhancing antitumor immunity in immune cells. This review has mainly summarized the most significant ion homeostasis impeding agents, including copper, zinc, calcium, and polyether, that presented remarkable potential in cancer therapeutics via enhanced antitumor immunity and apoptosis induction. Altogether, this study could provide a robust future perspective for developing cost-effective anticancerous drugs rapidly and cost-effectively, thereby combating the limitations of currently available drugs used in cancer treatment.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida 201306, India;
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida 201306, India;
| | - Huda A. Qari
- Department of Biological Science, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
| | - Tarun Kumar Upadhyay
- Department of Biotechnology, Parul Institute of Applied Sciences and Animal Cell Culture and Immunobiochemistry Lab, Centre of Research for Development, Parul University, Vadodara 391760, India;
| | - Abdulhameed F. Alkhateeb
- Department of Electrical & Computer Engineering, Faculty of Engineering, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
| | - Mohammad Oves
- Center of Excellence in Environmental Studies, King Abdulaziz University, Jeddah 21589, Saudi Arabia
- Institute of Multidisciplinary Research for Advanced Materials (IMRAM), Tohoku University, Sendai 980-8577, Japan
| |
Collapse
|
41
|
Mondal D, Ganguly S, Ghosh J, Pandey P, Roy S, Pipara A, Roy M, Biswas B. P-294 Colon carcinoma in adolescents and young adults, not so rare: Experience from an Indian cancer center. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
42
|
Garg A, Garg S, Pandey P, Shukla AK, Janadri S, Kori ML, Lodhi S. Fabrication and Evaluation of Carboxy Methyl Cellulose Anchored Dextran Bioinspired Hydrogel for Effective Delivery of Piroxicam. Indian J Pharm Sci 2022. [DOI: 10.36468/pharmaceutical-sciences.977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
43
|
Pandey P, Khan F. Moringa oleifera Plant as potent alternate to Chemical Coagulant in Water Purification. BRAZ J PHARM SCI 2022. [DOI: 10.1590/s2175-97902022e201158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023] Open
Affiliation(s)
- Pratibha Pandey
- Noida Institute of Engineering & Technology, India; Sharda University, India
| | - Fahad Khan
- Noida Institute of Engineering & Technology, India
| |
Collapse
|
44
|
Evans MJ, Gibson A, Fielding H, Ohal P, Pandey P, Kumar A, Singh SK, Airikkala-Otter I, Abela-Ridder B, Gamble L, Handel I, Bronsvoort BMDC, Mellanby RJ, Mazeri S. Free-roaming dog population dynamics in Ranchi, India. Res Vet Sci 2022; 143:115-123. [PMID: 35007799 DOI: 10.1016/j.rvsc.2021.12.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2021] [Revised: 12/03/2021] [Accepted: 12/28/2021] [Indexed: 11/24/2022]
Abstract
Rabies causes approximately 20,000 human deaths in India each year. Nearly all of these occur following dog bites. Large-scale, high-coverage dog rabies vaccination campaigns are the cornerstone of rabies elimination strategies in both human and dog populations, although this is particularly challenging to achieve in India as a large proportion of the dog population are free-roaming and unowned. Further, little is known about free-roaming dog ecology in India which makes defining optimum vaccination strategies difficult. In this study, data collected using a mobile phone application during three annual mass vaccination and neutering (surgical sterilisation of both males and females) campaigns of free-roaming dogs in Ranchi, India (during which a total of 43,847 vaccinations, 26,213 neuter surgeries and 28,172 re-sight observations were made) were interrogated, using two novel approaches to estimate the proportion of neutered dogs that were lost from the city (assumed due to mortality or migration) between campaign years. Analysis revealed high losses of neutered dogs each year, ranging from 25.3% (28.2-22.8) to 55.8% (57.0-54.6). We also estimated that the total population declined by 12.58% (9.89-15.03) over the three-year period. This demonstrates that there is a high turnover of free-roaming dogs and that despite neutering a large number of dogs in an annual sterilisation campaign, the decline in population size was modest over a three-year time period. These findings have significant implications for the planning of rabies vaccination campaigns and population management programmes as well as highlighting the need for further research into the demographics of free-roaming, unowned dogs in India.
Collapse
Affiliation(s)
- M J Evans
- The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Roslin, Midlothian, UK.
| | - A Gibson
- The Roslin Institute, The University of Edinburgh, Roslin, Midlothian, UK; Mission Rabies, Cranborne, Dorset, UK
| | - H Fielding
- The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Roslin, Midlothian, UK
| | - P Ohal
- Hope & Animal Trust, Ranchi, Jharkhand, India
| | - P Pandey
- Department of Agriculture Animal Husbandry and Cooperative, (Animal Husbandry Division) Govt. of Jharkhand, India
| | - A Kumar
- Hope & Animal Trust, Ranchi, Jharkhand, India
| | - S K Singh
- Hope & Animal Trust, Ranchi, Jharkhand, India
| | - I Airikkala-Otter
- WVS India, Gramya Bhavan/RDO-Building Complex, Aruvankadu, 643202 Nilgiris District, Tamil Nadu, India
| | - B Abela-Ridder
- Department for the Control of Neglected Tropical Diseases, World Health Organization, Genève, Switzerland
| | - L Gamble
- Mission Rabies, Cranborne, Dorset, UK
| | - I Handel
- The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Roslin, Midlothian, UK
| | - B M D C Bronsvoort
- The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Roslin, Midlothian, UK; The Roslin Institute, The University of Edinburgh, Roslin, Midlothian, UK
| | - R J Mellanby
- The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Roslin, Midlothian, UK; The Roslin Institute, The University of Edinburgh, Roslin, Midlothian, UK
| | - S Mazeri
- The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Roslin, Midlothian, UK; The Roslin Institute, The University of Edinburgh, Roslin, Midlothian, UK
| |
Collapse
|
45
|
Rowley J, Compton N, Djalali C, Hicks K, Price J, Zachariou N, Adhikari KP, Armstrong WR, Atac H, Baashen L, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biondo L, Biselli AS, Bondi M, Bossù F, Boiarinov S, Briscoe WJ, Brooks WK, Bulumulla D, Burkert VD, Carman DS, Carvajal JC, Celentano A, Chatagnon P, Chesnokov V, Chetry T, Ciullo G, Clark L, Cole PL, Contalbrigo M, Costantini G, Crede V, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Dupré R, Egiyan H, Ehrhart M, El Alaoui A, El Fassi L, Eugenio P, Fedotov G, Fegan S, Fersch R, Filippi A, Fradi A, Gavalian G, Girod FX, Glazier DI, Golubenko A, Gothe RW, Griffioen K, Guo L, Hafidi K, Hakobyan H, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Ilieva Y, Ireland DG, Isupov EL, Jenkins D, Jo HS, Joo K, Keller D, Khanal A, Khandaker M, Kim A, Korover I, Kripko A, Kubarovsky V, Kuhn SE, Lanza L, Leali M, Lenisa P, Livingston K, MacGregor IJD, Marchand D, Markov N, Marsicano L, Mascagna V, McCracken ME, McKinnon B, McLauchlin C, Meziani ZE, Migliorati S, Mineeva T, Mirazita M, Mokeev V, Munevar E, Munoz Camacho C, Nadel-Turonski P, Neupane K, Niccolai S, Niculescu G, O'Connell TR, Osipenko M, Ostrovidov AI, Pandey P, Paolone M, Pappalardo LL, Pasyuk E, Pogorelko O, Prok Y, Reed T, Ripani M, Ritman J, Rizzo A, Rosner G, Sabatie F, Salgado C, Schmidt A, Schumacher RA, Sharabian YG, Shrestha U, Sokhan D, Soto O, Sparveris N, Strakovsky II, Strauch S, Tyson R, Ungaro M, Venturelli L, Voskanyan H, Vossen A, Voutier E, Watts DP, Wei K, Wei X, Wishart R, Wood MH, Yale B, Yurov M, Zhang J, Zhao ZW. Improved Λp Elastic Scattering Cross Sections between 0.9 and 2.0 GeV/c as a Main Ingredient of the Neutron Star Equation of State. Phys Rev Lett 2021; 127:272303. [PMID: 35061432 DOI: 10.1103/physrevlett.127.272303] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Revised: 08/18/2021] [Accepted: 12/07/2021] [Indexed: 06/14/2023]
Abstract
Strange matter is believed to exist in the cores of neutron stars based on simple kinematics. If this is true, then hyperon-nucleon interactions will play a significant part in the neutron star equation of state. Yet, compared to other elastic scattering processes, there is very little data on Λ-N scattering. This experiment utilized the CEBAF Large Acceptance Spectrometer (CLAS) detector to study the Λp→Λp elastic scattering cross section in the incident Λ momentum range 0.9-2.0 GeV/c. These are the first data on this reaction since the 1970s. The new cross sections have significantly better accuracy and precision than the existing world data, and the techniques developed here can also be used in future experiments.
Collapse
Affiliation(s)
- J Rowley
- Ohio University, Athens, Ohio 45701, USA
| | - N Compton
- Ohio University, Athens, Ohio 45701, USA
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
| | - K Hicks
- Ohio University, Athens, Ohio 45701, USA
| | - J Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - K P Adhikari
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L Baashen
- Florida International University, Miami, Florida 33199, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | - M Battaglieri
- INFN, Sezione di Genova, 16146 Genova, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow 117259, Russia
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - L Biondo
- INFN, Sezione di Catania, 95123 Catania, Italy
- INFN, Sezione di Genova, 16146 Genova, Italy
- Universià degli Studi di Messina, 98166 Messina, Italy
| | - A S Biselli
- Fairfield University, Fairfield Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - W K Brooks
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - V Chesnokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - T Chetry
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - G Ciullo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Clark
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - P L Cole
- Lamar University, 4400 MLK Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - V Crede
- Florida State University, Tallahassee, Florida 32306, USA
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Dupré
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ehrhart
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - P Eugenio
- Florida State University, Tallahassee, Florida 32306, USA
| | - G Fedotov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - R Fersch
- Christopher Newport University, Newport News, Virginia 23606, USA
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - A Fradi
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Gavalian
- Old Dominion University, Norfolk, Virginia 23529, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - F X Girod
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - L Guo
- Florida International University, Miami, Florida 33199, USA
| | - K Hafidi
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - D Jenkins
- Virginia Tech, Blacksburg, Virginia 24061-0435, USA
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Keller
- Ohio University, Athens, Ohio 45701, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - M Khandaker
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - I Korover
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - P Lenisa
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - N Markov
- University of Connecticut, Storrs, Connecticut 06269, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Marsicano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
| | - M E McCracken
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - C McLauchlin
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Z E Meziani
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Migliorati
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - T Mineeva
- University of Connecticut, Storrs, Connecticut 06269, USA
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Munevar
- The George Washington University, Washington, D.C. 20052, USA
| | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Catholic University of America, Washington, D.C. 20064, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G Niculescu
- James Madison University, Harrisonburg, Virginia 22807, USA
| | - T R O'Connell
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A I Ostrovidov
- Florida State University, Tallahassee, Florida 32306, USA
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
| | - L L Pappalardo
- Università di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow 117259, Russia
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - J Ritman
- Institute fur Kernphysik (Juelich), 52425 Juelich, Germany
| | - A Rizzo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Università di Roma Tor Vergata, 00133 Rome, Italy
| | - G Rosner
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - F Sabatie
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - C Salgado
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
| | - R A Schumacher
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - D Sokhan
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - O Soto
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- University of Connecticut, Storrs, Connecticut 06269, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - A Vossen
- Duke University, Durham, North Carolina 27708-0305, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - K Wei
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M H Wood
- Canisius College, Buffalo, New York, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - B Yale
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Yurov
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - J Zhang
- Old Dominion University, Norfolk, Virginia 23529, USA
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
- University of South Carolina, Columbia, South Carolina 29208, USA
| |
Collapse
|
46
|
Chatagnon P, Niccolai S, Stepanyan S, Amaryan MJ, Angelini G, Armstrong WR, Atac H, Ayerbe Gayoso C, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biondo L, Biselli AS, Bondi M, Bossù F, Boiarinov S, Briscoe WJ, Brooks WK, Bulumulla D, Burkert VD, Carman DS, Carvajal JC, Caudron M, Celentano A, Chetry T, Ciullo G, Clark L, Cole PL, Contalbrigo M, Costantini G, Crede V, D'Angelo A, Dashyan N, Defurne M, De Vita R, Deur A, Diehl S, Djalali C, Dupré R, Egiyan H, Ehrhart M, El Alaoui A, El Fassi L, Elouadrhiri L, Fegan S, Fersch R, Filippi A, Gavalian G, Ghandilyan Y, Gilfoyle GP, Girod FX, Glazier DI, Golubenko AA, Gothe RW, Gotra Y, Griffioen KA, Guidal M, Guo L, Hakobyan H, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Hyde CE, Ilieva Y, Ireland DG, Isupov EL, Jo HS, Joo K, Kabir ML, Keller D, Khachatryan G, Khanal A, Kim A, Kim W, Kripko A, Kubarovsky V, Kuhn SE, Lanza L, Leali M, Lee S, Lenisa P, Livingston K, MacGregor IJD, Marchand D, Marsicano L, Mascagna V, McKinnon B, McLauchlin C, Migliorati S, Mirazita M, Mokeev V, Montgomery RA, Munoz Camacho C, Nadel-Turonski P, Naidoo P, Neupane K, O'Connell TR, Osipenko M, Ouillon M, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Phelps W, Pogorelko O, Poudel J, Price JW, Prok Y, Raue BA, Reed T, Ripani M, Rizzo A, Rossi P, Rowley J, Sabatié F, Schmidt A, Segarra EP, Sharabian YG, Shirokov EV, Shrestha U, Sokhan D, Soto O, Sparveris N, Strakovsky II, Strauch S, Tyler N, Tyson R, Ungaro M, Vallarino S, Venturelli L, Voskanyan H, Vossen A, Voutier E, Watts DP, Wei K, Wei X, Wishart R, Yale B, Zachariou N, Zhang J, Zhao ZW. First Measurement of Timelike Compton Scattering. Phys Rev Lett 2021; 127:262501. [PMID: 35029502 DOI: 10.1103/physrevlett.127.262501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/31/2021] [Revised: 10/21/2021] [Accepted: 11/11/2021] [Indexed: 06/14/2023]
Abstract
We present the first measurement of the timelike Compton scattering process, γp→p^{'}γ^{*}(γ^{*}→e^{+}e^{-}), obtained with the CLAS12 detector at Jefferson Lab. The photon beam polarization and the decay lepton angular asymmetries are reported in the range of timelike photon virtualities 2.25<Q^{'2}<9 GeV^{2}, squared momentum transferred 0.1<-t<0.8 GeV^{2}, and average total center-of-mass energy squared s=14.5 GeV^{2}. The photon beam polarization asymmetry, similar to the beam-spin asymmetry in deep virtual Compton scattering, is sensitive to the imaginary part of the Compton form factors and provides a way to test the universality of the generalized parton distributions. The angular asymmetry of the decay leptons accesses the real part of the Compton form factors and thus the D-term in the parametrization of the generalized parton distributions.
Collapse
Affiliation(s)
- P Chatagnon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - S Niccolai
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - S Stepanyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M J Amaryan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - G Angelini
- The George Washington University, Washington, D.C. 20052, USA
| | - W R Armstrong
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Atac
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - C Ayerbe Gayoso
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - N A Baltzell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L Barion
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - M Bashkanov
- University of York, York YO10 5DD, United Kingdom
| | - M Battaglieri
- INFN, Sezione di Genova, 16146 Genova, Italy
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - I Bedlinskiy
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - F Benmokhtar
- Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, USA
| | - A Bianconi
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - L Biondo
- INFN, Sezione di Genova, 16146 Genova, Italy
- INFN, Sezione di Catania, 95123 Catania, Italy
- Universit'a degli Studi di Messina, 98166 Messina, Italy
| | - A S Biselli
- Fairfield University, Fairfield, Connecticut 06824, USA
| | - M Bondi
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - F Bossù
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - S Boiarinov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W J Briscoe
- The George Washington University, Washington, D.C. 20052, USA
| | - W K Brooks
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - D Bulumulla
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - V D Burkert
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D S Carman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J C Carvajal
- Florida International University, Miami, Florida 33199, USA
| | - M Caudron
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A Celentano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - T Chetry
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
- Ohio University, Athens, Ohio 45701, USA
| | - G Ciullo
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Clark
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - P L Cole
- Lamar University, 4400 M. L. King, Jr. Boulevard, P.O. Box 10046, Beaumont, Texas 77710, USA
| | | | - G Costantini
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - V Crede
- Florida State University, Tallahassee, Florida 32306, USA
| | - A D'Angelo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome, Italy
| | - N Dashyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - M Defurne
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - R De Vita
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Diehl
- University of Connecticut, Storrs, Connecticut 06269, USA
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - C Djalali
- Ohio University, Athens, Ohio 45701, USA
| | - R Dupré
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - H Egiyan
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Ehrhart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A El Alaoui
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - L El Fassi
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - L Elouadrhiri
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Fegan
- University of York, York YO10 5DD, United Kingdom
| | - R Fersch
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - A Filippi
- INFN, Sezione di Torino, 10125 Torino, Italy
| | - G Gavalian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Ghandilyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - G P Gilfoyle
- University of Richmond, Richmond, Virginia 23173, USA
| | - F X Girod
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D I Glazier
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A A Golubenko
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - R W Gothe
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - Y Gotra
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K A Griffioen
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - M Guidal
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - L Guo
- Florida International University, Miami, Florida 33199, USA
| | - H Hakobyan
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - M Hattawy
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - T B Hayward
- University of Connecticut, Storrs, Connecticut 06269, USA
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - D Heddle
- Christopher Newport University, Newport News, Virginia 23606, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Hobart
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M Holtrop
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
| | - C E Hyde
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - Y Ilieva
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - D G Ireland
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - E L Isupov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - H S Jo
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - K Joo
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M L Kabir
- Mississippi State University, Mississippi State, Mississippi 39762-5167, USA
| | - D Keller
- University of Virginia, Charlottesville, Virginia 22901, USA
| | | | - A Khanal
- Florida International University, Miami, Florida 33199, USA
| | - A Kim
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - W Kim
- Kyungpook National University, Daegu 41566, Republic of Korea
| | - A Kripko
- II Physikalisches Institut der Universitaet Giessen, 35392 Giessen, Germany
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S E Kuhn
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - L Lanza
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
| | - M Leali
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - S Lee
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - P Lenisa
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - K Livingston
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | | | - D Marchand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - L Marsicano
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - V Mascagna
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi dell'Insubria, 22100 Como, Italy
| | - B McKinnon
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - C McLauchlin
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Migliorati
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - M Mirazita
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
| | - V Mokeev
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - C Munoz Camacho
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Naidoo
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - K Neupane
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - T R O'Connell
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - M Osipenko
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - M Ouillon
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Pandey
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - M Paolone
- New Mexico State University, P.O. Box 30001, Las Cruces, New Mexico 88003, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L L Pappalardo
- Universita' di Ferrara, 44121 Ferrara, Italy
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - R Paremuzyan
- University of New Hampshire, Durham, New Hampshire 03824-3568, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Pasyuk
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Phelps
- Christopher Newport University, Newport News, Virginia 23606, USA
- The George Washington University, Washington, D.C. 20052, USA
| | - O Pogorelko
- National Research Centre Kurchatov Institute-ITEP, Moscow, 117259, Russia
| | - J Poudel
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J W Price
- California State University, Dominguez Hills, Carson, California 90747, USA
| | - Y Prok
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - B A Raue
- Florida International University, Miami, Florida 33199, USA
| | - T Reed
- Florida International University, Miami, Florida 33199, USA
| | - M Ripani
- INFN, Sezione di Genova, 16146 Genova, Italy
| | - A Rizzo
- INFN, Sezione di Roma Tor Vergata, 00133 Rome, Italy
- Universita' di Roma Tor Vergata, 00133 Rome, Italy
| | - P Rossi
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Rowley
- Ohio University, Athens, Ohio 45701, USA
| | - F Sabatié
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - A Schmidt
- The George Washington University, Washington, D.C. 20052, USA
| | - E P Segarra
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - Y G Sharabian
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E V Shirokov
- Skobeltsyn Institute of Nuclear Physics, Lomonosov Moscow State University, 119234 Moscow, Russia
| | - U Shrestha
- University of Connecticut, Storrs, Connecticut 06269, USA
- Ohio University, Athens, Ohio 45701, USA
| | - D Sokhan
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - O Soto
- INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
- Universidad Técnica Federico Santa María, Casilla 110-V Valparaíso, Chile
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - I I Strakovsky
- The George Washington University, Washington, D.C. 20052, USA
| | - S Strauch
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - N Tyler
- University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Tyson
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Ungaro
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Vallarino
- INFN, Sezione di Ferrara, 44100 Ferrara, Italy
| | - L Venturelli
- INFN, Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Brescia, 25123 Brescia, Italy
| | - H Voskanyan
- Yerevan Physics Institute, 375036 Yerevan, Armenia
| | - A Vossen
- Duke University, Durham, North Carolina 27708-0305, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Voutier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D P Watts
- University of York, York YO10 5DD, United Kingdom
| | - K Wei
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - X Wei
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Wishart
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - B Yale
- College of William and Mary, Williamsburg, Virginia 23187-8795, USA
| | - N Zachariou
- University of York, York YO10 5DD, United Kingdom
| | - J Zhang
- University of Virginia, Charlottesville, Virginia 22901, USA
| | - Z W Zhao
- Duke University, Durham, North Carolina 27708-0305, USA
| |
Collapse
|
47
|
Upadhyay TK, Ali MI, Khan F, Goel H, Mathur M, Goyal K, Moin S, Pandey P, Tanwar P, Sharangi AB, Gautam SDC, Kapdi JK, Patel KI, Patel MV, Parmar AM, Kamal MA. Nanoparticles mediated target-specific drug delivery in prostate cancer: In-depth review. Curr Med Chem 2021; 29:4170-4184. [PMID: 34939536 DOI: 10.2174/0929867329666211221112312] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2021] [Revised: 11/12/2021] [Accepted: 11/18/2021] [Indexed: 02/08/2023]
Abstract
Nanotechnology has been extensively exploited for its enormous therapeutics and diagnostics potential in the management of multiple disorders. It employs nanomaterials as drug carriers with enhanced efficacy and limited side effects on normal tissues. A lot of nanomaterials have been studied and produced, imminently reforming the treatment and diagnostics of numerous malignancies including cancer. The purpose of the present study is to explore the role of nanotechnology-based devices/therapies that have a vital function in the therapeutics and diagnostics of cancer with potential impact at three levels: early detection, tumor imaging, and drug delivery methods. Concentrating on cancer, promising nanotechnology-based approaches have been planned to satisfy the need for targeted specificity of traditional agents of chemotherapeutics, in addition to early recognition of malignant and precancerous lesions. Prostate cancer is the fifth utmost well-known cancer worldwide and the second most usually detected cancer in men. Therefore, there is a crucial need to improve therapeutic prospects for the diagnosis and treatment of prostate cancer via exploitation of the potential of nanomaterials for cell-targeted specificity and improved primary diagnosis of precancerous tumours. The present review, therefore, focuses on summarizing all prospective applications of nanotechnology in the prognosis and diagnosis of prostate cancer, which would further help researchers to elucidate a more potent therapeutic approach for the better management of prostate cancer in the days ahead.
Collapse
Affiliation(s)
- Tarun Kumar Upadhyay
- Department of Biotechnology, Animal Cell Culture and Immunobiochemistry Lab, Parul Institute of Applied Science and Centre of Research for Development, Parul University, Vadodara, Gujarat, 391760. India
| | - Mohammed Irfan Ali
- School of Applied Science, Suresh Gyan Vihar University, Jaipur, 302017. India
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida, 201306. India
| | - Harsh Goel
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi. India
| | - Manas Mathur
- School of Agriculture, Suresh Gyan Vihar University, Jaipur, 302017. India
| | - Keshav Goyal
- Department of Microbiology, Ram Lal Anand College, University of Delhi. India
| | - Sarmad Moin
- School of Applied Science, Suresh Gyan Vihar University, Jaipur, 302017. India
| | - Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering & Technology, Greater Noida, 201306. India
| | - Pranay Tanwar
- Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi. India
| | - Amit Baran Sharangi
- Department of Plantation, Spices, Medicinal & Aromatic Crops, BCKV-Agricultural University, Mohanpur, Nadia, West Bengal. India
| | - Saloni Dinesh Chandra Gautam
- Department of Biotechnology, Animal Cell Culture and Immunobiochemistry Lab, Parul Institute of Applied Science and Centre of Research for Development, Parul University, Vadodara, Gujarat, 391760. India
| | - Jhanvi Kiran Kapdi
- Department of Biotechnology, Animal Cell Culture and Immunobiochemistry Lab, Parul Institute of Applied Science and Centre of Research for Development, Parul University, Vadodara, Gujarat, 391760. India
| | - Kruti Indravadan Patel
- Department of Biotechnology, Animal Cell Culture and Immunobiochemistry Lab, Parul Institute of Applied Science and Centre of Research for Development, Parul University, Vadodara, Gujarat, 391760. India
| | - Meghna Vipulbhai Patel
- Department of Biotechnology, Animal Cell Culture and Immunobiochemistry Lab, Parul Institute of Applied Science and Centre of Research for Development, Parul University, Vadodara, Gujarat, 391760. India
| | - Amisha M Parmar
- Department of Biotechnology, Animal Cell Culture and Immunobiochemistry Lab, Parul Institute of Applied Science and Centre of Research for Development, Parul University, Vadodara, Gujarat, 391760. India
| | - Mohammad Amjad Kamal
- West China School of Nursing / Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, Sichuan. China
| |
Collapse
|
48
|
Acharya BN, Ahirwar R, Dhiman S, Yadav K, Pandey P, Sukumaran D. Deltamethrin Microencapsulation in Emulsion Paint Binder and Its Long-Term Efficacy Against Dengue Vector Aedes aegypti. Front Public Health 2021; 9:686122. [PMID: 34760859 PMCID: PMC8572806 DOI: 10.3389/fpubh.2021.686122] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2021] [Accepted: 09/23/2021] [Indexed: 11/13/2022] Open
Abstract
Various control interventions have been effective in the control of arthropod vectors to a certain extent; still, sustained vector control is an existing problem globally. Insecticide-based formulations have been found to be useful, however the proper delivery of active molecules to target vectors is important. Currently, synthetic pyrethroid deltamethrin (DM) has been microencapsulated in the emulsion paint binder and evaluated for long-term effectiveness against dengue vector Aedes aegypti. Different compositions of emulsion binder were prepared by varying the content of monomer and DM. A selection was made for the composition yielding the best combination of properties like solid content, intrinsic viscosity, and DM content. Developed formulation was tested against laboratory-reared and pathogen-free Ae. aegypti mosquitoes. Encapsulation of DM in emulsion binder during polymerization showed a uniform distribution. The optimized formulation was stable and did not have a considerable plasticizing effect. Scanning electron microscopy revealed that grain-like micro crystals of DM and surfactant sodium lauryl sulfate (SDS) were uniformly distributed on the formulation surface. The best optimized formulation was highly effective against dengue vector Ae. aegypti and found to provide efficacy for up to 18 months of application. The knockdown time (KDT) values KDT10 and KDT50 were 7.4 min (95% CI: 5.6–9.1) and 22.1 min (95% CI: 19.7–24.3) respectively, whereas 24 h corrected mortality was 90% (95% CI: 82.5–97.5) after 18 months of application (T18). The probit model used to determine knockdown values did not deviate from the linearity and displayed normal distribution of knockdown % with time for different formulations (p ≥ 0.1). Presently developed DM microencapsulated emulsion binder was stable, smooth, and uniform. The binder displayed excellent anti-insect property and was capable of providing long-term effectiveness against dengue vectors Ae. aegypti. Such a formulation after field-scale evaluation could be very useful in attaining long-term protection from arthropod vectors.
Collapse
Affiliation(s)
- B N Acharya
- Synthetic Chemistry Division, Defence R&D Establishment, Gwalior, India
| | - Rajkumar Ahirwar
- Synthetic Chemistry Division, Defence R&D Establishment, Gwalior, India
| | - Sunil Dhiman
- Vector Management Division, Defence R&D Establishment, Gwalior, India
| | - Kavita Yadav
- Vector Management Division, Defence R&D Establishment, Gwalior, India
| | - Pratibha Pandey
- Electron Microscopy Division, Defence R&D Establishment, Gwalior, India
| | | |
Collapse
|
49
|
Pandey P, Khan F, Qari HA, Oves M. Rutin (Bioflavonoid) as Cell Signaling Pathway Modulator: Prospects in Treatment and Chemoprevention. Pharmaceuticals (Basel) 2021; 14:1069. [PMID: 34832851 PMCID: PMC8621917 DOI: 10.3390/ph14111069] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2021] [Revised: 10/16/2021] [Accepted: 10/18/2021] [Indexed: 12/11/2022] Open
Abstract
Cancer is a complex ailment orchestrated by numerous intrinsic and extrinsic pathways. Recent research has displayed a deep interest in developing plant-based cancer therapeutics for better management of the disease and limited side effects. A wide range of plant-derived compounds have been reported for their anticancer potential in the quest of finding an effective therapeutic approach. Rutin (vitamin P) is a low-molecular weight flavonoid glycoside (polyphenolic compound), abundantly present in various vegetables, fruits (especially berries and citrus fruits), and medicinal herbs. Numerous studies have delineated several pharmacological properties of rutin such as its antiprotozoal, antibacterial, anti-inflammatory, antitumor, antiviral, antiallergic, vasoactive, cytoprotective, antispasmodic, hypolipidemic, antihypertensive, and antiplatelet properties. Specifically, rutin-mediated anticancerous activities have been reported in several cancerous cell lines, but the most common scientific evidence, encompassing several molecular processes and interactions, including apoptosis pathway regulation, aberrant cell signaling pathways, and oncogenic genes, has not been thoroughly studied. In this direction, we attempted to project rutin-mediated oncogenic pathway regulation in various carcinomas. Additionally, we also incorporated advanced research that has uncovered the notable potential of rutin in the modulation of several key cellular functions via interaction with mRNAs, with major emphasis on elucidating direct miRNA targets of rutin as well as the process needed to transform these approaches for developing novel therapeutic interventions for the treatment of several cancers.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida 201306, India;
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, 19, Knowledge Park-II, Institutional Area, Greater Noida 201306, India;
| | - Huda A. Qari
- Department of Biological Science, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
| | - Mohammad Oves
- Center of Excellence in Environmental Studies, King Abdulaziz University, Jeddah 21589, Saudi Arabia
| |
Collapse
|
50
|
Pandey P, Khan F, Alzahrani FA, Qari HA, Oves M. A Novel Approach to Unraveling the Apoptotic Potential of Rutin (Bioflavonoid) via Targeting Jab1 in Cervical Cancer Cells. Molecules 2021; 26:molecules26185529. [PMID: 34577000 PMCID: PMC8472561 DOI: 10.3390/molecules26185529] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2021] [Revised: 08/31/2021] [Accepted: 09/04/2021] [Indexed: 01/29/2023] Open
Abstract
Rutin has been well recognized for possessing numerous pharmacological and biological activities in several human cancer cells. This research has addressed the inhibitory potential of rutin against the Jab1 oncogene in SiHa cancer cells, which is known to inactivate various tumor suppressor proteins including p53 and p27. Further, the inhibitory efficacy of rutin via Jab1 expression modulation in cervical cancer has not been yet elucidated. Hence, we hypothesized that rutin could exhibit strong inhibitory efficacy against Jab1 and, thereby, induce significant growth arrest in SiHa cancer cells in a dose-dependent manner. In our study, the cytotoxic efficacy of rutin on the proliferation of a cervical cancer cell line (SiHa) was exhibited using MTT and LDH assays. The correlation between rutin and Jab1 mRNA expression was assessed by RT-PCR analysis and the associated events (a mechanism) with this downregulation were then explored via performing ROS assay, DAPI analysis, and expression analysis of apoptosis-associated signaling molecules such as Bax, Bcl-2, and Caspase-3 and -9 using qRT-PCR analysis. Results exhibit that rutin produces anticancer effects via inducing modulation in the expression of oncogenes as well as tumor suppressor genes. Further apoptosis induction, caspase activation, and ROS generation in rutin-treated SiHa cancer cells explain the cascade of events associated with Jab1 downregulation in SiHa cancer cells. Additionally, apoptosis induction was further confirmed by the FITC-Annexin V/PI double staining method. Altogether, our research supports the feasibility of developing rutin as one of the potent drug candidates in cervical cancer management via targeting one such crucial oncogene associated with cervical cancer progression.
Collapse
Affiliation(s)
- Pratibha Pandey
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida 201306, India; or
| | - Fahad Khan
- Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida 201306, India; or
- Correspondence: or (F.K.); or (M.O.); Tel.: +91-8923580628 (F.K.); +966-650399857 (M.O.)
| | - Faisal Abdulrahman Alzahrani
- Department of Biochemistry, Faculty of Science, Embryonic Stem Cells Unit, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
| | - Huda A. Qari
- Department of biological Science, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia;
| | - Mohammad Oves
- Center of Excellence in Environmental Studies, King Abdulaziz University, Jeddah 21589, Saudi Arabia
- Correspondence: or (F.K.); or (M.O.); Tel.: +91-8923580628 (F.K.); +966-650399857 (M.O.)
| |
Collapse
|